,drug_name,section_name,gpt_output
0,KYPROLIS,adverse reactions,"cardiac toxicities, acute renal failure, tumor lysis syndrome, pulmonary toxicity, pulmonary hypertension, dyspnea, hypertension, venous thrombosis, infusion reactions, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, posterior reversible encephalopathy syndrome (PRES), anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, pneumonia, respiratory tract infection, pulmonary embolism, constipation, lymphopenia, leukopenia, vomiting, chills, asthenia, nasopharyngitis, bronchitis, hypocalcemia, hyperglycemia, back pain, arthralgia, pain in extremity, musculoskeletal pain, decreased appetite, hypercalcemia, muscle spasms, dizziness, insomnia, renal failure, epistaxis, hypertension, febrile neutropenia, cardiac arrest, cardiac failure congestive, myocardial infarction, myocardial ischemia, cataract, blurred vision, abdominal pain, abdominal pain upper, dyspepsia, toothache, infusion site reaction, multi-organ failure, pain, hepatobiliary disorders, hepatic failure, influenza, sepsis, urinary tract infection, viral infection, hyperkalemia, hyperuricemia, hypoalbuminemia, hypomagnesemia, hyponatremia, hypophosphatemia, musculoskeletal chest pain, myalgia, hypoesthesia, paresthesia, anxiety, renal impairment, dysphonia, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, rash, deep vein thrombosis, hypotension, dehydration, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS)."
1,KYPROLIS,warnings and precautions,"cardiac failure, myocardial infarction, myocardial ischemia, Acute Renal Failure, Tumor Lysis Syndrome (TLS), Acute Respiratory Distress Syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, pneumonitis, interstitial lung disease, Pulmonary Hypertension, Dyspnea, Hypertension, hypertensive crisis, hypertensive emergency, Venous Thrombosis, deep venous thrombosis, pulmonary embolism, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic thrombocytopenic purpura, hemolytic uremic syndrome (TTP/HUS), Posterior reversible encephalopathy syndrome (PRES), Reversible Posterior Leukoencephalopathy Syndrome (RPLS), Embryo-fetal Toxicity, cardiac arrest, congestive heart failure, pulmonary edema, decreased ejection fraction, restrictive cardiomyopathy, renal impairment, renal failure, New York Heart Association Class III and IV heart failure, conduction abnormalities, arterial hypertension, serum transaminases increase"
2,MULTAQ,adverse reactions,"heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, bradycardia, rashes (generalized rash, macular rash, maculo-papular rash, erythematous rash), pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, increases in creatinine, QTc prolongation, atrial flutter with 1:1 atrioventricular conduction, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis"
3,MULTAQ,boxed warnings,"decompensated heart failure, permanent atrial fibrillation, symptomatic heart failure, recent decompensation requiring hospitalization, NYHA Class IV heart failure, stroke, death, hospitalization for heart failure"
4,MULTAQ,warnings and precautions,"atrial fibrillation (AF), liver injury, hepatic injury, pulmonary toxicity, hypokalemia, hypomagnesemia, renal impairment, teratogen, NYHA Class IV heart failure, decompensated heart failure, cardiovascular death, stroke, new onset heart failure, worsening heart failure, hepatocellular liver injury, acute liver failure, interstitial lung disease, pneumonitis, pulmonary fibrosis, QT interval prolongation, pre-renal azotemia, acute renal failure"
5,JUBLIA,adverse reactions,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
6,TEFLARO,adverse reactions,"Hypersensitivity Reactions, Clostridium difficile-Associated Diarrhea, Direct Coombs' Test Seroconversion, Diarrhea, Nausea, Rash, Constipation, Vomiting, Increased Transaminases, Hypokalemia, Phlebitis, Anemia, Eosinophilia, Neutropenia, Thrombocytopenia, Bradycardia, Palpitations, Abdominal Pain, Pyrexia, Hepatitis, Anaphylaxis, Clostridium difficile Colitis, Hyperglycemia, Hyperkalemia, Dizziness, Convulsion, Renal Failure, Urticaria, Agranulocytosis."
7,TEFLARO,warnings and precautions,"serious hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea (CDAD), diarrhea, drug-induced hemolytic anemia, anemia, fatal colitis, morbidity, mortality, drug-resistant bacteria"
8,DATSCAN,adverse reactions,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, serious adverse reactions, rash, pruritis, injection site pain"
9,DATSCAN,warnings and precautions,"Hypersensitivity reactions, anaphylactic reactions, skin erythema, pruritis, thyroid neoplasia"
10,TIVICAY,adverse reactions,"Hypersensitivity reactions, Hepatitis B, Hepatitis C, Fat Redistribution, Immune Reconstitution Syndrome, Insomnia, Fatigue, Headache, Treatment-emergent Adverse Drug Reactions, Depressions, Abnormal dreams, Dizziness, Nausea, Diarrhea, Rash, Vertigo, Abdominal pain, Abdominal discomfort, Flatulence, Upper abdominal pain, Vomiting, Hepatitis, Myositis, Suicidal ideation, Suicidal attempt, Suicidal behavior, Suicidal completion, Renal impairment, Pruritus, Hyperglycemia, Lipase elevation, Neutropenia, Immune reconstitution inflammatory syndrome (IRIS), Liver enzyme elevations, Increased ALT, Increased AST, Renal glomerular dysfunction, Increased serum creatinine, Bilirubin elevation."
11,TIVICAY,warnings and precautions,"Hypersensitivity reactions, rash, constitutional findings, organ dysfunction, liver injury, hepatitis B, hepatitis C, transaminase elevations, hepatotoxicity, hepatic disease, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
12,TAFINLAR,adverse reactions,"New Primary Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, BRAF V600E Unresectable or Metastatic Melanoma, Hypophosphatemia, Increased alkaline phosphatase, Hyponatremia, Pancreatitis, Hypersensitivity, bullous rash, Interstitial nephritis, BRAF V600E or V600K Unresectable or Metastatic Melanoma, Stomatitis, Asthenia, Cellulitis, folliculitis, paronychia, rash pustular, Skin papilloma, hyperhidrosis, Hypertension, Leukopenia, Lymphopenia, Neutropenia, Anemia, Thrombocytopenia, Increased AST, increased alkaline phosphatase, Increased ALT, Hyperbilirubinemia, Hyperglycemia, Increased GGT, Hyponatremia, Hypoalbuminemia, Hypophosphatemia, Hypokalemia, Increased creatinine, Hypomagnesemia, Hyperkalemia, Hypercalcemia, Hypocalcemia, QT Prolongation."
13,TAFINLAR,warnings and precautions,"Retinal vein occlusion, Interstitial lung disease, new primary malignancies, cutaneous malignancies, non-cutaneous malignancies, tumor promotion in BRAF Wild-Type Melanoma, hemorrhage, venous thromboembolism, deep vein thrombosis, pulmonary embolism, cardiomyopathy, ocular toxicities, serious febrile reactions, pyrexia, serious skin toxicity, rash, Grade 2 rash, Grade 3 rash, Grade 4 rash, hyperglycemia, diabetes, hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, hemolytic anemia, Embryofetal Toxicity, fetal harm, teratogenic, embryotoxic, hypotension, rigors, chills, dehydration, renal failure, intracranial hemorrhage, gastric hemorrhage, visual disturbances, Retinal Pigment Epithelial Detachment (RPED), uveitis, iritis, cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, basal cell carcinoma, pancreatic adenocarcinoma, colorectal carcinoma, head and neck carcinoma, glioblastoma, skin toxicities, secondary infections, intolerance, non-hormonal contraception, hormonal contraception inefficacy."
14,HORIZANT,adverse reactions,"somnolence/sedation, dizziness, Restless Legs Syndrome (RLS), Postherpetic Neuralgia (PHN), headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, confusional state, insomnia, breast enlargement, gynecomastia, elevated creatine kinase"
15,HORIZANT,warnings and precautions,"Driving impairment, Somnolence, Sedation, Dizziness, Suicidal thoughts or behaviors, Restless Legs Syndrome (RLS), Postherpetic Neuralgia (PHN), Depression, Eosinophilia, Fever, Rash, Lymphadenopathy, Hepatitis, Nephritis, Hematological abnormalities, Myocarditis, Myositis, Viral infection, Tumorigenicity, Pancreatic acinar cell adenoma, Pancreatic carcinoma, Breast cancer, Brain tumors, Lung cancer, Adrenal tumor, Non-Hodgkin's lymphoma, Endometrial carcinoma in situ, Prostate cancer."
16,IMBRUVICA,adverse reactions,"hemorrhage, infections, cytopenias, atrial fibrillation, second primary malignancies, tumor lysis syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, renal failure, creatinine increased, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, headache, hyperuricemia, disease progression, uric acid levels elevated, mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), stomatitis, dyspepsia, sinusitis, urinary tract infection, skin infections, pyrexia, asthenia, petechiae, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, laceration, anxiety, insomnia, hypertension, subdural hematoma, chills, oropharyngeal pain, peripheral neuropathy, second malignancies, contusion, vision blurred, Waldenstrom's macroglobulinemia (WM), gastroesophageal reflux disease, pruritus, arthropathy, skin cancer, hypersensitivity reactions, anaphylactic shock, urticaria, angioedema."
17,IMBRUVICA,warnings and precautions,"Hemorrhage, bleeding, infections, fever, cytopenias, neutropenia, thrombocytopenia, anemia, atrial fibrillation, atrial flutter, second primary malignancies, skin cancers, non-skin carcinomas, non-melanoma skin cancer, tumor lysis syndrome (TLS), embryo-fetal toxicity, fetal harm, malformations, reduced fetal weights, progressive multifocal leukoencephalopathy (PML), subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, bruising, petechiae."
18,ULORIC,adverse reactions,"liver function abnormalities, nausea, arthralgia, rash, hyperuricemia, gout, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis, leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis, cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, decreased/increased appetite, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms/twitching/tightness/weakness, musculoskeletal pain/stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, decreased libido, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, abnormal hair growth, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration/altered pigmentation, skin lesion, abnormal skin odor, urticaria, flushing, hot flush, hypertension, hypotension, hepatic failure, jaundice, hepatic disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens-Johnson Syndrome."
19,ULORIC,warnings and precautions,"gout flare, cardiovascular thromboembolic events, cardiovascular deaths, non-fatal myocardial infarctions, non-fatal strokes, hepatic failure, liver injury, transaminase elevations, drug-induced liver injury"
20,CIMZIA,adverse reactions,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, headache, hypertension, back pain, pharyngitis, acute bronchitis, fatigue, herpes infections, lower respiratory tract infections, cellulitis, pyelonephritis, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, psoriasis (pustular and palmoplantar), sarcoidosis."
21,CIMZIA,boxed warnings,"serious infections, malignancy, hospitalization, death, tuberculosis, disseminated disease, extrapulmonary disease, latent tuberculosis, invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial sepsis, Legionella infections, Listeria infections, chronic infection, recurrent infection, lymphoma, cancer, opportunistic infections"
22,CIMZIA,warnings and precautions,"serious infections, active infection, invasive fungal infections, systemic illness, mycoses, lymphoma, malignancies, heart failure, worsening heart failure, new onset heart failure, anaphylaxis, serious allergic reactions, hepatitis B virus reactivation, demyelinating disease, exacerbation of demyelinating disease, new onset demyelinating disease, cytopenias, pancytopenia, lupus-like syndrome, opportunistic infections, bacterial infections, mycobacterial infections, viral infections, parasitic infections, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, tuberculosis, chronic infection, recurrent infection, latent tuberculosis, hepatitis B, hepatosplenic T-cell lymphoma (HSTCL), acute leukemia, chronic leukemia, congestive heart failure (CHF), hypersensitivity reactions, reactivation of hepatitis B virus (HBV), central nervous system demyelinating disease, multiple sclerosis, peripheral demyelinating disease, Guillain-Barre syndrome, seizure disorder, optic neuritis, peripheral neuropathy, aplastic anemia, leukopenia, thrombocytopenia, blood dyscrasias, immunosuppression."
23,KALYDECO,adverse reactions,"transaminase elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, hypoglycemia, rhinitis, arthralgia, bacteria in sputum, infections and infestations, investigations, aspartate aminotransferase increased, blood glucose increased, hepatic enzyme increased, musculoskeletal and connective tissue disorders, musculoskeletal chest pain, myalgia, nervous system disorders, sinus headache, respiratory disorders, thoracic disorders, mediastinal disorders, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, skin disorders, subcutaneous tissue disorders, acne"
24,KALYDECO,warnings and precautions,"elevated transaminases, transaminase elevations, liver function test abnormalities, cataracts, non-congenital lens opacities"
25,FULYZAQ,adverse reactions,"HIV-positive, upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count"
26,FULYZAQ,warnings and precautions,"infectious diarrhea, non-infectious diarrhea"
27,QUTENZA,adverse reactions,"Application-Associated Pain, Increase in Blood Pressure, Application Site Erythema, Application Site Pain, Application Site Pruritus, Application Site Papules, Postherpetic Neuralgia, Application Site Edema, Application Site Swelling, Application Site Dryness, Nasopharyngitis, Bronchitis, Sinusitis, Nausea, Vomiting, Pruritus, Hypertension, Application Site Urticaria, Application Site Paresthesia, Application Site Dermatitis, Application Site Hyperesthesia, Application Site Excoriation, Application Site Warmth, Application Site Anesthesia, Application Site Bruising, Application Site Inflammation, Application Site Exfoliation, Peripheral Edema, Headache, Burning Sensation, Peripheral Sensory Neuropathy, Dizziness, Dysgeusia, Hyperesthesia, Hypoesthesia, Cough, Throat Irritation, Abnormal Skin Odor"
28,QUTENZA,warnings and precautions,"irritation of eyes, irritation of airway, coughing, sneezing, transient increases in blood pressure, hypertension, cardiovascular effects, cerebrovascular events"
29,GRANIX,adverse reactions,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Sickle Cell Disease, Capillary Leak Syndrome, Tumor Growth Stimulatory Effects on Malignant Cells, Bone Pain, Leukocytosis, Myalgia, Headache, Vomiting, Sweet's Syndrome, Cutaneous Vasculitis, Thrombocytopenia."
30,GRANIX,warnings and precautions,"Splenic Rupture, 
Acute Respiratory Distress Syndrome (ARDS), 
Allergic Reactions, 
Angioneurotic Edema, 
Dermatitis Allergic, 
Drug Hypersensitivity, 
Hypersensitivity, 
Rash, 
Pruritic Rash, 
Urticaria, 
Sickle Cell Crisis, 
Capillary Leak Syndrome (CLS), 
Hypotension, 
Hypoalbuminemia, 
Edema, 
Hemoconcentration, 
Tumor Growth, 
Myeloid Malignancies, 
Myelodysplasia."
31,COARTEM,adverse reactions,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, hypersensitivity reactions, serious adverse reactions, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, malaria, nasopharyngitis, Plasmodium falciparum infection, rhinitis, aspartate aminotransferase increased, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions (bullous eruption)."
32,COARTEM,warnings and precautions,"QT prolongation, hypokalemia, hypomagnesemia, symptomatic cardiac arrhythmias, clinically relevant bradycardia, severe cardiac disease, congenital prolongation of the QT interval, sudden death, disturbances of electrolyte balance, decreased efficacy, recrudescence, P. falciparum infection, severe hepatic impairment, renal impairment, Plasmodium vivax infection, relapsing malaria"
33,APTIOM,adverse reactions,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Multiorgan Hypersensitivity, Anaphylactic Reactions, Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, partial-onset seizures, asthenia, gait disturbance, peripheral edema, Urinary tract infections, fall, Diarrhea, Constipation, Abdominal pain, Gastritis, Balance disorder, Dysarthria, Memory impairment, Nystagmus, Depression, Insomnia, Cough, Rash, Hypertension, decreases in hemoglobin, decreases in hematocrit, increases in total cholesterol, increases in triglycerides, increases in LDL, increases in creatine phosphokinase"
34,APTIOM,warnings and precautions,"Suicidal behavior and ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Anaphylactic Reactions, Angioedema, Hyponatremia, Neurological Adverse Reactions, Withdrawal of APTIOM, Status epilepticus, Drug Induced Liver Injury, Hepatic effects, Abnormal Thyroid Function Tests, Depression, Stevens-Johnson Syndrome (SJS), Toxic epidermal necrolysis (TEN), Multiorgan hypersensitivity, Fever, Rash, Lymphadenopathy, Hepatitis, Nephritis, Hematological abnormalities, Myocarditis, Myositis, Eosinophilia, Acute viral infection, Laryngeal edema, Seizures, Nausea, Vomiting, Dehydration, Gait instability, Injury, Hospitalization, Hypochloremia, Dizziness, Disturbance in Gait and Coordination, Somnolence, Fatigue, Cognitive Dysfunction, Visual Changes, Hazardous Activities, Elevated transaminases, Elevated bilirubin, Hypothyroidism."
35,PROLIA,adverse reactions,"Hypocalcemia, Serious Infections, Dermatologic Adverse Reactions, Osteonecrosis of the Jaw, Atypical Subtrochanteric and Diaphyseal Femoral Fractures, Back pain, Pain in extremity, Musculoskeletal pain, Hypercholesterolemia, Cystitis, Arthralgia, Nasopharyngitis, Pancreatitis, Malignancies, Anemia, Angina pectoris, Atrial fibrillation, Vertigo, Abdominal pain upper, Flatulence, Gastroesophageal reflux disease, Edema peripheral, Asthenia, Upper respiratory tract infection, Pneumonia, Pharyngitis, Herpes zoster, Bone pain, Myalgia, Spinal osteoarthritis, Sciatica, Insomnia, Rash, Pruritus, Constipation, Dermatitis, Eczema, Rashes, New malignancies, Cataracts."
36,PROLIA,warnings and precautions,"hypersensitivity, anaphylactic reactions, anaphylaxis, hypocalcemia, osteonecrosis of the jaw (ONJ), atypical femoral fractures, serious infections, skin infections, cellulitis, dermatologic reactions, dermatitis, rashes, eczema, bone pain, joint pain, muscle pain, suppression of bone turnover, renal impairment, malabsorption syndromes, hypoparathyroidism, thyroid surgery, parathyroid surgery, excision of small intestine, dialysis, co-morbid disorders, periodontal disease, dental disease, anemia, coagulopathy, infection, ill-fitting dentures, endocarditis, opportunistic infections, immunosuppression"
37,BLINCYTO,adverse reactions,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, Pyrexia, Peripheral Edema, Hypokalemia, Tremor, Rash, Constipation, Pneumonia, Sepsis, Device-related Infection, Encephalopathy, Overdose, Confusion, Staphylococcal Bacteremia, Headache, Anemia, Thrombocytopenia, Leukopenia, Diarrhea, Colitis, Enteritis, Neutropenic Colitis, Abdominal Pain, Vomiting, Fatigue, Chills, Chest Pain, Cytokine Release Syndrome, Fungal Infections, Viral Infections, Hypomagnesemia, Hyperglycemia, Decreased Appetite, Hypophosphatemia, Back Pain, Bone Pain, Arthralgia, Dizziness, Insomnia, Cough, Dyspnea, Hypotension, Hypertension, Leukocytosis, Lymphopenia, Tachycardia, Edema, Cytokine Storm, Decreased Immunoglobulins, Increased Blood Bilirubin, Increased Gamma-Glutamyl-Transferase, Hypoalbuminemia, Paresthesia, Aphasia, Convulsion, Memory Impairment, Cognitive Disorder, Speech Disorder, Capillary Leak Syndrome, Hypersensitivity, Bronchospasm"
38,BLINCYTO,boxed warnings,"Cytokine Release Syndrome (CRS), Neurological toxicities"
39,BLINCYTO,warnings and precautions,"infections, cytokine release syndrome (CRS), infusion reactions, pyrexia, headache, nausea, asthenia, hypotension, increased alanine aminotransferase, increased aspartate aminotransferase, increased total bilirubin, disseminated intravascular coagulation (DIC), capillary leak syndrome (CLS), hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), neurological toxicities, encephalopathy, convulsions, speech disorders, disturbances in consciousness, confusion and disorientation, coordination and balance disorders, sepsis, pneumonia, bacteremia, opportunistic infections, catheter-site infections, tumor lysis syndrome (TLS), neutropenia, febrile neutropenia, leukoencephalopathy"
40,STENDRA,adverse reactions,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection (URI), bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, dizziness, arthralgia, diarrhea, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, gastroenteritis viral, Non-arteritic anterior ischemic optic neuropathy (NAION), decreased vision, vision loss"
41,STENDRA,warnings and precautions,"erectile dysfunction (ED), cardiovascular status, hypotension, Non Arteritic Ischemic Optic Neuropathy (NAION), loss of vision, decrease or loss of hearing, tinnitus, dizziness, left ventricular outflow obstruction, aortic stenosis, idiopathic hypertrophic subaortic stenosis, autonomic control of blood pressure, myocardial infarction, stroke, life-threatening arrhythmia, coronary revascularization, resting hypotension, hypertension, unstable angina, congestive heart failure, prolonged erection, priapism, anatomical deformation of the penis, angulation, cavernosal fibrosis, Peyronie's disease, conditions predisposing to priapism, sickle cell anemia, multiple myeloma, leukemia, optic disc crowding, symptomatic hypotension, bleeding disorders, peptic ulceration, sexually transmitted diseases, Human Immunodeficiency Virus (HIV)."
42,XIAFLEX,adverse reactions,"Dupuytren's contracture, tendon ruptures, Peyronie's disease, corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in extremity, pruritus, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, blood blister, injection site hematoma, ecchymosis, penile hematoma, penile swelling, penile pain, penile ecchymoses, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain, severe injection site hematoma, injection site bruising, injection site discomfort, scrotal swelling, injection site edema, immunogenicity (not a condition but an immune response to the drug)."
43,XIAFLEX,boxed warnings,"Corporal rupture (penile fracture), serious penile injury, Peyronie's disease, penile ecchymoses, hematoma, sudden penile detumescence, severe penile hematoma."
44,XIAFLEX,warnings and precautions,"tendon rupture, serious injury, injected finger/hand, permanent injury, ligament damage, skin laceration, Corporal rupture (penile fracture), serious injury to the penis, hypersensitivity reactions, anaphylaxis, abnormal coagulation, Dupuytren's contracture, flexor tendon ruptures, tissue damage, pulley rupture, complex regional pain syndrome (CRPS), sensory abnormality of the hand, Peyronie's disease, penile ecchymoses, hematoma, sudden penile detumescence, severe penile hematoma, allergic reactions, pruritus, ecchymosis/contusion, injection site hemorrhage, IgE-anti-drug antibodies, bleeding, coagulation disorders."
45,XEOMIN,adverse reactions,"hypersensitivity, dysphagia, breathing difficulties, cervical dystonia, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, blepharospasm, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, glabellar lines, facial paresis, injection site hematoma, eyelid edema, facial pain, injection site swelling, sensation of pressure, blepharospasm, eye disorder, immunogenicity, eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscle spasm, dysarthria, myalgia"
46,XEOMIN,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death, spasticity, cervical dystonia"
47,XEOMIN,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, compromised respiratory function, dysphagia, neuromuscular disorders, cervical dystonia, corneal exposure, corneal ulceration, perforation, diplopia, blepharospasm, ptosis, glabellar lines, asthenia, generalized muscle weakness, blurred vision, dysphonia, dysarthria, urinary incontinence, breathing difficulties, hypersensitivity reactions, anaphylaxis, serum sickness, urticaria, soft tissue edema, dyspnea, aspiration, respiratory failure, peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, neuromuscular junctional disorders, myasthenia gravis, Lambert-Eaton syndrome, ectropion, narrow angle glaucoma, ecchymosis, viral diseases, Creutzfeldt-Jakob disease (CJD)."
48,GILOTRIF,adverse reactions,"diarrhea, bullous skin disorders, exfoliative skin disorders, interstitial lung disease, hepatic toxicity, keratitis, rash, dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, dyspnea, fatigue, hypokalemia, pulmonary toxicity, interstitial lung disease (ILD)-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, diastolic dysfunction, left ventricular dysfunction, ventricular dilation, gastrointestinal disorders, cheilitis, skin and subcutaneous tissue disorders, infections and infestations, cystitis, metabolism and nutrition disorders, respiratory, thoracic and mediastinal disorders, epistaxis, rhinorrhea, investigations, weight decreased, general disorders and administration site conditions, pyrexia, eye disorders, conjunctivitis, laboratory abnormalities, alanine aminotransferase increased, aspartate aminotransferase increased, pancreatitis"
49,GILOTRIF,warnings and precautions,"Diarrhea, Dehydration, Renal failure, Bullous Skin Disorders, Exfoliative Skin Disorders, Interstitial lung disease (ILD), Hepatic toxicity, Fatal hepatic impairment, Keratitis, Embryofetal toxicity, Renal impairment, Grade 3 diarrhea, Loose bowel movements, Bullous lesions, Blistering lesions, Exfoliating lesions, Cutaneous reactions, Rash, Erythema, Acneiform rash, Palmar-plantar erythrodysesthesia syndrome, Lung infiltration, Pneumonitis, Acute respiratory distress syndrome, Alveolitis allergic, Liver test abnormalities, Acute eye inflammation, Lacrimation, Light sensitivity, Blurred vision, Eye pain, Red eye, Ulcerative keratitis, Dry eye, Abortions, Maternal toxicity"
50,TREANDA,adverse reactions,"- Myelosuppression
- Infections
- Anaphylaxis
- Infusion Reactions
- Tumor Lysis Syndrome
- Skin Reactions
- Other Malignancies
- Extravasation injury
- Pyrexia (Fever)
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Anorexia
- Cough
- Headache
- Weight decreased
- Dyspnea (Shortness of breath)
- Rash
- Stomatitis
- Lymphopenia
- Anemia
- Leukopenia
- Thrombocytopenia
- Neutropenia
- Asthenia
- Fatigue
- Malaise
- Weakness
- Dry mouth
- Somnolence
- Mucosal inflammation
- Hypertension
- Hypertensive crisis
- Nasopharyngitis
- Infection
- Herpes simplex
- Hyperuricemia
- Pruritus
- Febrile neutropenia
- Pneumonia
- Hypokalemia (Low potassium)
- Dehydration
- Tachycardia
- Constipation
- Stomatitis
- Abdominal pain
- Dyspepsia
- Gastroesophageal reflux disease
- Abdominal pain upper
- Abdominal distension
- Edema peripheral
- Chest pain
- Infusion site pain
- Pain
- Catheter site pain
- Herpes zoster
- Upper respiratory tract infection
- Urinary tract infection
- Sinusitis
- Oral candidiasis
- Back pain
- Arthralgia
- Pain in extremity
- Bone pain
- Dizziness
- Dysgeusia
- Insomnia
- Anxiety
- Depression
- Pharyngolaryngeal pain
- Wheezing
- Nasal congestion
- Dry skin
- Night sweats
- Hyperhidrosis
- Hypotension
- Hemolysis
- Taste disorder
- Atypical pneumonia
- Sepsis
- Erythema
- Dermatitis
- Skin necrosis
- Acute renal failure
- Cardiac failure
- Pulmonary fibrosis
- Myelodysplastic syndrome
- Anaphylaxis
- Phlebitis
- Pneumocystis jiroveci pneumonia
- Pneumonitis
- Stevens-Johnson Syndrome (SJS)
- Toxic Epidermal Necrolysis (TEN)"
51,TREANDA,warnings and precautions,"Myelosuppression, Death, Infections, Fever, Anaphylaxis, Infusion Reactions, Anaphylactic reactions, Tumor Lysis Syndrome, Acute renal failure, Skin Reactions, SJS (Stevens-Johnson syndrome), TEN (Toxic Epidermal Necrolysis), Other Malignancies, Pre-malignant diseases, Malignant diseases, Myelodysplastic syndrome, Myeloproliferative disorders, Acute myeloid leukemia, Bronchial carcinoma, Extravasation, Embryo-fetal toxicity, Neutropenic sepsis, Diffuse alveolar hemorrhage, Thrombocytopenia, Pneumonia, Opportunistic infection, CMV (Cytomegalovirus), Allergic-type reactions, Toxic skin reactions, Bullous exanthema, Erythema, Swelling, Pain, Infection, Necrosis, Resorptions, Skeletal malformations, Visceral malformations, Decreased fetal body weights."
52,CHOLINE,adverse reactions,injection site reaction
53,CHOLINE,warnings and precautions,"poor imaging performance, allergic reactions, radiation risk, recurrent prostate cancer, lung carcinoma, brain tumors, tissue inflammation, prostatic hyperplasia, false positive results, false negative results, anaphylaxis, increased risk for cancer"
54,ERWINAZE,adverse reactions,"Hypersensitivity reactions, Pancreatitis, Glucose intolerance, Thrombosis, Hemorrhage, Systemic hypersensitivity, Hyperglycemia, Transaminases abnormal, Fever, Local reactions, Vomiting, Nausea, Hyperbilirubinemia, Abdominal pain, Discomfort, Diarrhea, Allergic reactions, Coagulopathy, Hyperlipidemia, Ketoacidosis, CNS events, Hepatobiliary disorders, Pancreatic disorders."
55,ERWINAZE,warnings and precautions,"hypersensitivity reactions, anaphylaxis, severe pancreatitis, hemorrhagic pancreatitis, glucose intolerance, hyperglycemia, thrombosis, hemorrhage, pancreatitis, serious thrombotic events, sagittal sinus thrombosis, pulmonary embolism."
56,TRULICITY,adverse reactions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, Nausea, Diarrhea, Vomiting, Abdominal pain, Decreased appetite, Dyspepsia, Fatigue, Constipation, Flatulence, Abdominal distension, Gastroesophageal reflux disease, Eructation, Type 2 diabetes, Documented symptomatic hypoglycemia, Severe hypoglycemia, Heart Rate Increase, Tachycardia, Sinus tachycardia, Immunogenicity, Systemic hypersensitivity, Severe urticaria, Systemic rash, Facial edema, Lip swelling, Injection-site reactions, Injection-site rash, Erythema, PR Interval Prolongation, First Degree Atrioventricular Block, Amylase increase, Lipase increase, Retinopathy"
57,TRULICITY,boxed warnings,"thyroid C-cell tumors, adenomas, carcinomas, medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)"
58,TRULICITY,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Macrovascular outcomes, Medullary Thyroid Carcinoma (MTC), Multiple Endocrine Neoplasia Type 2 (MEN 2), Thyroid disease, Thyroid nodules, Abdominal pain, Acute renal failure, Worsening of chronic renal failure, Severe gastrointestinal disease, Gastroparesis."
59,ADREVIEW,adverse reactions,"hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, pheochromocytoma, neuroblastoma, heart failure, hematoma, bruising"
60,ADREVIEW,warnings and precautions,"hypersensitivity reactions, anaphylactic reactions, withdrawal signs and symptoms, serious reactions, severe renal impairment, radiation exposure, imaging errors, pheochromocytoma, neuroblastoma, congestive heart failure, benzyl alcohol toxicity, hypotension, metabolic acidosis, kernicterus, Gasping Syndrome, thyroid neoplasia, Parkinson's disease, multiple system atrophy, hypertension"
61,DOTAREM,adverse reactions,"Nephrogenic systemic fibrosis (NSF), hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, site inflammation, extravasation, warmth, bradycardia, tachycardia, arrhythmia, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis."
62,DOTAREM,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), impaired elimination, kidney disease, Chronic kidney disease, Acute kidney injury, renal function, hypertension, diabetes."
63,DOTAREM,warnings and precautions,"Nephrogenic Systemic Fibrosis, impaired elimination of GBCAs, Hypersensitivity, Anaphylactoid reactions, Anaphylactic reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, death, emergency cardiorespiratory support, chronic severe kidney disease, acute kidney injury, chronic moderate kidney disease, chronic mild kidney disease, fatal fibrosis, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, rapid decrease in kidney function, surgery-related kidney injury, severe infection-related kidney injury, injury-related kidney injury, drug-induced kidney toxicity, chronically reduced renal function, diabetes mellitus, chronic hypertension, NSF risk, contrast agent's elimination, Hemodialysis, circulatory collapse, reaction to contrast media, bronchial asthma, allergic disorders, Extravasation, tissue irritation, Injection Site Reactions, renal impairment, renal dysfunction, renal function assessments."
64,PRADAXA,adverse reactions,"bleeding, gastritis-like symptoms, gastrointestinal hemorrhage, stroke, systemic embolism, non-valvular atrial fibrillation, dyspepsia, nausea, upper abdominal pain, diarrhea, intracranial hemorrhage, intracerebral hemorrhage, hemorrhagic stroke, subarachnoid hemorrhage, subdural hemorrhage, gastrointestinal adverse reactions, GERD (gastroesophageal reflux disease), esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, deep vein thrombosis, pulmonary embolism, myocardial infarction, angioedema, thrombocytopenia, esophageal ulcer"
65,PRADAXA,boxed warnings,"thrombotic events, spinal/epidural hematoma, pathological bleeding, long-term paralysis, permanent paralysis, neurological impairment"
66,PRADAXA,warnings and precautions,"bleeding, thrombotic events, thromboembolic events, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, major bleeding, post-operative pericardial effusions, atrial fibrillation, valvular heart disease, bioprosthetic heart valves, renal impairment, spinal hematoma, paralysis, deep venous thrombosis, pulmonary embolism."
67,ELIQUIS,adverse reactions,"Here's a list of medical conditions and synonyms as they appear in the text:

thrombotic events, bleeding, spinal/epidural anesthesia or puncture, systemic embolism, atrial fibrillation, major bleeding, intracranial hemorrhage (ICH), hemorrhagic stroke, gastrointestinal (GI) bleeding, fatal bleeding, hypersensitivity reactions, anaphylactic reactions, allergic edema, syncope, deep vein thrombosis (DVT), pulmonary embolism (PE), anemia, postoperative anemia, hemorrhagic anemia, contusion, hemorrhage, hematoma, vaginal hemorrhage, urethral hemorrhage, postprocedural hemorrhage, postprocedural hematoma, wound hemorrhage, vessel puncture site hematoma, catheter site hemorrhage, transaminases increased, alanine aminotransferase increased, alanine aminotransferase abnormal, aspartate aminotransferase increased, gamma-glutamyltransferase increased, thrombocytopenia, platelet count decreases, hypotension, procedural hypotension, respiratory disorders, epistaxis, gastrointestinal disorders, gastrointestinal hemorrhage, hematemesis, melena, hematochezia, hepatobiliary disorders, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, renal disorders, hematuria, injury, wound secretion, incision-site hemorrhage, incision-site hematoma, operative hemorrhage, gingival bleeding, hemoptysis, muscle hemorrhage, ocular hemorrhage, conjunctival hemorrhage, rectal hemorrhage, hemorrhagic anemia, hemorrhoidal hemorrhage, traumatic hematoma, periorbital hematoma, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, hemorrhage, ecchymosis, skin hemorrhage, petechiae, eye disorders, retinal hemorrhage, eye hemorrhage, investigations, blood urine present, occult blood positive, occult blood, red blood cells urine positive, general disorders, injection-site hematoma, vessel puncture-site hematoma."
68,ELIQUIS,boxed warnings,"thrombotic events, spinal/epidural hematoma, pathological bleeding, paralysis"
69,ELIQUIS,warnings and precautions,"serious bleeding, blood loss, thrombotic events, stroke, atrial fibrillation, pathological bleeding, hemorrhage, active pathological hemorrhage, spinal/epidural anesthesia, epidural/spinal hematoma, paralysis, neurological impairment, prosthetic heart valves, acute pulmonary embolism (PE), hemodynamically unstable patients, thrombolysis, pulmonary embolectomy."
70,ZERBAXA,adverse reactions,"Hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, increased ALT, increased AST, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, increased mortality, cardiac disorders (tachycardia, angina pectoris), gastrointestinal disorders (ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic), general disorders and administration site conditions (infusion site reactions), infections and infestations (candidiasis, oropharyngeal, fungal urinary tract infection), investigations (increased serum gamma-glutamyl transferase (GGT), increased serum alkaline phosphatase, positive Coombs test), metabolism and nutrition disorders (hyperglycemia, hypomagnesemia, hypophosphatemia), nervous system disorders (ischemic stroke), respiratory, thoracic and mediastinal disorders (dyspnea), skin and subcutaneous tissue disorders (urticaria), vascular disorders (venous thrombosis)."
71,ZERBAXA,warnings and precautions,"decreased efficacy, baseline CrCl of 30 to <=50 mL/min, changing renal function, serious hypersensitivity reactions, anaphylactic reactions, hypersensitivity to beta-lactam antibacterial drugs, Clostridium difficile-associated diarrhea (CDAD), mild diarrhea, fatal colitis, drug-resistant bacteria"
72,FERRIPROX,adverse reactions,"chromaturia, nausea, vomiting, abdominal pain, increased alanine aminotransferase, arthralgia, neutropenia, agranulocytosis, decreased plasma zinc concentrations, elevated ALT, diarrhea, dyspepsia, decreased neutrophil count, weight increased, increased aspartate aminotransferase, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, peripheral edema, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, increased blood bilirubin, increased blood creatinine phosphokinase, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritus, urticaria, rash, Henoch-Schönlein purpura, hypotension, hypertension."
73,FERRIPROX,boxed warnings,"agranulocytosis, neutropenia, serious infections, infection, death"
74,FERRIPROX,warnings and precautions,"infection, fetal harm, agranulocytosis, neutropenia, embryofetal death, malformations, increased ALT values, increased serum ALT levels, increased AST levels, decreased plasma zinc concentrations"
75,DALVANCE,adverse reactions,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, increased hepatic transaminases, increased blood alkaline phosphatase, increased international normalized ratio."
76,DALVANCE,warnings and precautions,"serious hypersensitivity (anaphylactic) reactions, skin reactions, glycopeptide allergy, rapid intravenous infusion reactions, Red-Man Syndrome, flushing of the upper body, urticaria, pruritus, rash, ALT elevations, hepatic effects, liver tests abnormalities, Clostridium difficile-associated diarrhea (CDAD), mild diarrhea, fatal colitis, development of drug-resistant bacteria."
77,ARCAPTA,adverse reactions,"asthma-related death, asthma, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, Chronic Obstructive Pulmonary Disease (COPD), dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, asthma exacerbation, hypersensitivity reactions, paradoxical bronchospasm, tachycardia, heart rate increase, palpitations, pruritus, rash, dizziness"
78,ARCAPTA,boxed warnings,"asthma-related death, asthma"
79,ARCAPTA,warnings and precautions,"COPD (chronic obstructive pulmonary disease), acute symptoms, cardiovascular effects, asthma-related death, asthma, immediate hypersensitivity reactions, paradoxical bronchospasm, cardiovascular disorders, convulsive disorders, thyrotoxicosis, sensitivity to sympathomimetic drugs, cardiac arrhythmias, hypertension, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia"
80,CERDELGA,adverse reactions,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease (GERD), constipation, palpitations, rash"
81,CERDELGA,warnings and precautions,"cardiac disease, pre-existing cardiac disease, long QT syndrome, cardiac arrhythmias, congestive heart failure, acute myocardial infarction, bradycardia, heart block, ventricular arrhythmia"
82,GADAVIST,adverse reactions,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, headache, nausea, dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash, Pruritus, Erythema, Dyspnea, Paresthesia, Hypotension, Urticaria, Face edema, Eyelid edema, Flushing, Loss of consciousness, Convulsion, Parosmia, Tachycardia, Palpitation, Dry mouth, Malaise, Feeling cold, Cardiac arrest."
83,GADAVIST,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), impaired elimination of drugs, fatal or debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, Chronic kidney disease, severe kidney disease, Acute kidney injury, reduced renal function, hypertension, diabetes."
84,GADAVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, impaired elimination of GBCAs, Anaphylactic reactions, hypersensitivity reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, death, chronic severe kidney disease, acute kidney injury, chronic moderate kidney disease, chronic mild kidney disease, fatal fibrosis, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, surgery-related kidney injury, severe infection-related kidney injury, injury-related kidney injury, drug-induced kidney toxicity, chronic reduced renal function, diabetes mellitus, chronic hypertension, bronchial asthma, allergic disorders, Extravasation, Injection Site Reactions, Overestimation of Extent of Malignant Disease, MRI of the Breast."
85,ZYKADIA,adverse reactions,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease, Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, convulsion, pneumonia, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, esophageal disorder, rash, neuropathy, vision disorder, Hemoglobin decreased, Alanine transaminase increased, Aspartate transaminase increased, Creatinine increased, Glucose increased, Phosphate decreased, Lipase increased, Bilirubin increased"
86,ZYKADIA,warnings and precautions,"Severe or Persistent Gastrointestinal Toxicity, diarrhea, nausea, vomiting, abdominal pain, Hepatotoxicity, liver laboratory tests, liver function abnormalities, Interstitial Lung Disease (ILD), Pneumonitis, QT Interval Prolongation, QTc interval prolongation, congestive heart failure, bradyarrhythmias, electrolyte abnormalities, Hyperglycemia, fasting glucose, elevated blood sugar, Bradycardia, heart rate reduction, blood pressure anomalies, Pancreatitis, elevation of lipase, elevation of amylase, Embryofetal Toxicity, fetal harm, skeletal anomalies, pregnancy-related risks, reproductive potential risks."
87,XALKORI,adverse reactions,"Hepatotoxicity, Interstitial Lung Disease, Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, Diarrhea, Nausea, Vomiting, Constipation, Edema, Elevated Transaminases, Upper Respiratory Infection, Decreased Appetite, Dysgeusia, Dyspnea, Pulmonary Embolism, Septic Shock, Acute Respiratory Failure, Diabetic Ketoacidosis, Dysphagia, Abdominal Pain, Pyrexia, Weight Increased, Pain in Extremity, Muscle Spasm, Dizziness, Headache, Fatigue, Neuropathy, Gait Disturbance, Hypoaesthesia, Muscular Weakness, Neuralgia, Peripheral Neuropathy, Paraesthesia, Peripheral Sensory Neuropathy, Polyneuropathy, Sensory Disturbance, Rash, Renal Cyst, Syncope, Neutropenia, Lymphopenia, Hypophosphatemia, ALT Elevation, AST Elevation, Hematology, Chemistry, Hypokalemia, Acute Respiratory Distress Syndrome, Arrhythmia, Pneumonia, Respiratory Failure, Sepsis, Hepatic Failure"
88,XALKORI,warnings and precautions,"hepatotoxicity, fatal hepatotoxicity, Interstitial Lung Disease (ILD), Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, Embryofetal Toxicity, drug-induced hepatotoxicity, elevations in alanine aminotransferase, elevations in aspartate aminotransferase, transaminase elevations, severe visual loss, vision loss, optic atrophy, optic nerve disorder, embryotoxicity, fetotoxicity"
89,BEPREVE,adverse reactions,"mild taste, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, swelling of tongue, swelling of throat"
90,BEPREVE,warnings and precautions,"contamination, contact lens-related irritation, eye redness"
91,EDARBI,adverse reactions,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, renal impairment, low hemoglobin, low hematocrit, low red blood cell (RBC) counts, abnormal platelet counts, abnormal WBC counts, rash, pruritus, angioedema"
92,EDARBI,boxed warnings,fetal toxicity
93,EDARBI,warnings and precautions,"volume depletion, salt depletion, renal impairment, fetal toxicity, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, hypotension, renal failure, neonatal morbidity, neonatal death, symptomatic hypotension, severe congestive heart failure, renal artery stenosis, oliguria, progressive azotemia, acute renal failure, increases in serum creatinine, increases in blood urea nitrogen."
94,POTIGA,adverse reactions,"retinal abnormalities, vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior, ideation, withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, nausea, constipation, dyspepsia, influenza, weight increased, paresthesia, amnesia, dysphasia, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhidrosis, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy."
95,POTIGA,boxed warnings,"retinal abnormalities, potential vision loss, retinal pigment dystrophies, damage to the photoreceptors, abnormal visual acuity, retinal pigmentary abnormalities, vision changes"
96,POTIGA,warnings and precautions,"urinary retention, urologic symptoms, skin discoloration, neuropsychiatric symptoms, confusional state, psychotic symptoms, hallucinations, dizziness, somnolence, QT prolongation, suicidal thoughts, behaviors, retinal abnormalities, potential vision loss, retinal pigment dystrophies, retinal pigmentary abnormalities, vision loss, hydronephrosis, renal function impairment, benign prostatic hyperplasia (BPH), psychosis, depression, mood changes, withdrawal seizures, epilepsy, psychiatric conditions, morbidity, mortality."
97,TUDORZA,adverse reactions,"paradoxical bronchospasm, narrow-angle glaucoma, urinary retention, immediate hypersensitivity reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, COPD, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching"
98,TUDORZA,warnings and precautions,"acute episodes of bronchospasm, paradoxical bronchospasm, narrow-angle glaucoma, urinary retention, prostatic hyperplasia, bladder-neck obstruction, immediate hypersensitivity reactions, anaphylaxis, angioedema, bronchospasm, hypersensitivity to milk proteins, COPD (Chronic Obstructive Pulmonary Disease)"
99,PROMACTA,adverse reactions,"Hepatic Decompensation, Chronic Hepatitis C, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, Immune Thrombocytopenia (ITP), Nausea, Diarrhea, Upper Respiratory Tract Infection, Vomiting, Increased ALT, Myalgia, Urinary Tract Infection, Nasopharyngitis, Rhinitis, Anemia, Pyrexia, Fatigue, Headache, Decreased Appetite, Influenza-like Illness, Asthenia, Insomnia, Cough, Pruritus, Chills, Alopecia, Peripheral Edema, Severe Aplastic Anemia, Oropharyngeal Pain, Increased AST, Pharyngitis, Back Pain, Influenza, Paresthesia, Rash, Musculoskeletal Pain, Blood Alkaline Phosphatase Increased, Dry Mouth, Hyperbilirubinemia, Cataract, Serum Liver Test Abnormalities, Hepatobiliary Laboratory Abnormalities, Portal Vein Thromboses, Abdominal Pain, Toothache, Vitamin D Deficiency, Decreased Libido, Dyspnea, Dizziness, Pain in Extremity, Febrile Neutropenia, Ecchymosis, Muscle Spasms, Transaminases Increased, Arthralgia, Rhinorrhea, Cytogenetic Abnormalities, Thrombotic Microangiopathy, Acute Renal Failure"
100,PROMACTA,boxed warnings,"hepatic decompensation, chronic hepatitis C"
101,PROMACTA,warnings and precautions,"Hepatotoxicity, Thrombotic/Thromboembolic Complications, Portal Vein Thrombosis, Chronic Liver Disease, Hepatic Decompensation, Chronic Hepatitis C, Thrombocytopenia, Ascites, Encephalopathy, Liver Enzyme Elevations, Hyperbilirubinemia, Liver Injury, Hepatic Decompensation, Factor V Leiden, ATIII deficiency, Antiphospholipid Syndrome, Cataracts"
102,INLYTA,adverse reactions,"advanced RCC (advanced Renal Cell Carcinoma), hypertension, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation, fistula formation, thyroid dysfunction, wound healing complications, RPLS (Reversible Posterior Leukoencephalopathy Syndrome), proteinuria, elevation of liver enzymes, hepatic impairment, fetal development, diarrhea, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia (hand-foot syndrome), weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hemoglobin decreased, lymphocytes (absolute) decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, alkaline phosphatase (ALP) increased, hyperglycemia, amylase increased, alanine aminotransferase (ALT) increased, aspartate aminotransferase (AST) increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased, hypercalcemia"
103,INLYTA,warnings and precautions,"hypertension, hypertensive crisis, arterial thrombotic events, venous thrombotic events, hemorrhagic events, brain metastasis, gastrointestinal bleeding, cardiac failure, gastrointestinal perforation, fistula formation, hypothyroidism, hyperthyroidism, wound healing complications, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), proteinuria, elevation of liver enzymes, hepatic impairment, fetal harm, teratogenic effects, embryotoxic effects, fetotoxic effects"
104,NORTHERA,adverse reactions,"supine hypertension, hyperpyrexia, confusion, ischemic heart disease, arrhythmias, congestive heart failure, headache, dizziness, nausea, hypertension, fatigue, Parkinson's disease, multiple system atrophy, pure autonomic failure, dopamine beta-hydroxylase deficiency, non-diabetic autonomic neuropathy, increased blood pressure, falls, urinary tract infections, syncope"
105,NORTHERA,boxed warnings,supine hypertension
106,NORTHERA,warnings and precautions,"supine hypertension, cardiovascular risk, hyperpyrexia, confusion, ischemic heart disease, arrhythmias, congestive heart failure, allergic reactions, neuroleptic malignant syndrome (NMS), fever, hyperthermia, muscle rigidity, involuntary movements, altered consciousness, mental status changes, bronchial asthma, aspirin hypersensitivity"
107,JARDIANCE,adverse reactions,"Hypotension, Impairment in Renal Function, Hypoglycemia, Genital Mycotic Infections, Urinary Tract Infections, Increased Low-Density Lipoprotein Cholesterol (LDL-C), Dyslipidemia, Arthralgia, Nausea, Volume Depletion, Dehydration, Orthostatic Hypotension, Syncope, Increased Urination, Polyuria, Pollakiuria, Nocturia, Diabetic nephropathy, Retinopathy, Neuropathy, Upper respiratory tract infection, Thirst, Polydipsia, Vaginitis bacterial, Cystitis, Asymptomatic bacteriuria, Balanoposthitis, Balanitis, Scrotal abscess, Penile infection, Phimosis, Asymptomatic bacteriuria, Hematocrit increased."
108,JARDIANCE,warnings and precautions,"hypotension, renal impairment, low systolic blood pressure, diuretics-induced complications, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C (Low-Density Lipoprotein Cholesterol), macrovascular outcomes."
109,FANAPT,adverse reactions,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, abdominal discomfort, nausea, diarrhea, nasopharyngitis, upper respiratory tract infection, vision blurred, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, akathisia, bradykinesia, dyskinesia, dystonia, parkinsonism, anemia, iron deficiency anemia, leukopenia, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, congestive heart failure, acute cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, allergic conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, conjunctival hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, pitting edema, cardiac edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation"
110,FANAPT,boxed warnings,"dementia-related psychosis, death, heart failure, sudden death, pneumonia"
111,FANAPT,warnings and precautions,"dementia-related psychosis, increased risk of death, cerebrovascular-related adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome (NMS), Tardive dyskinesia, Hyperglycemia, diabetes mellitus, polydipsia, polyuria, polyphagia, weakness, Dyslipidemia, Weight Gain, metabolic changes, cardiovascular risk, cerebrovascular risk, Seizures, Orthostatic hypotension, Dizziness, tachycardia, syncope, Leukopenia, Neutropenia, Agranulocytosis, low white blood cell count (WBC), Suicide, Priapism, cognitive impairment, motor impairment, hyperpyrexia, muscle rigidity, altered mental status, autonomic instability, irregular pulse, blood pressure changes, diaphoresis, cardiac dysrhythmia, elevated creatine phosphokinase, myoglobinuria, rhabdomyolysis, acute renal failure, extrapyramidal signs and symptoms (EPS), central anticholinergic toxicity, heat stroke, drug fever, primary central nervous system (CNS) pathology, undesirable alterations in lipids, body weight gain, hypokalemia, hypomagnesemia, significant electrolyte disturbances, significant cardiovascular illness, recent acute myocardial infarction, uncompensated heart failure, cardiac arrhythmia, conditions that lower seizure threshold, high risk of torsade de pointes, dehydration, hypovolemia, antihypertensive medications, Hyperprolactinemia, hypothalamic GnRH suppression, reduced pituitary gonadotropin secretion, reproductive function impairment, Galactorrhea, amenorrhea, gynecomastia, impotence, decreased bone density, breast cancer, Body Temperature Regulation, Dysphagia, Esophageal dysmotility, aspiration pneumonia, Alzheimer's dementia, Ketoacidosis, hyperosmolar coma, low absolute neutrophil count."
112,TANZEUM,adverse reactions,"Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Upper respiratory tract infection, Diarrhea, Nausea, Injection site reaction, Cough, Back pain, Arthralgia, Sinusitis, Influenza, Vomiting, Gastroesophageal reflux disease, Dyspepsia, Constipation, Injection site hematoma, Injection site erythema, Injection site rash, Injection site hypersensitivity, Injection site hemorrhage, Injection site pruritus, Peripheral neuropathy, Retinopathy, Pneumonia, Atrial fibrillation, Atrial flutter, Appendicitis, Liver enzyme abnormalities, Alanine aminotransferase (ALT) increase, Gamma glutamyltransferase (GGT) increase, Heart rate increase"
113,TANZEUM,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)"
114,TANZEUM,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Macrovascular Outcomes, Carcinogenicity, Thyroid C-cell adenomas, Thyroid C-cell carcinomas, Medullary Thyroid Carcinoma, MTC, MEN 2, Acute Pancreatitis, Acute Renal Failure, Chronic Renal Failure, Serum Calcitonin Elevated, Thyroid Nodules, Serum Calcitonin Testing"
115,EYLEA,adverse reactions,"Endophthalmitis, retinal detachments, increased intraocular pressure, Thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, Neovascular Age-Related Macular Degeneration, Macular Edema Following Retinal Vein Occlusion, CRVO, BRVO, ocular hyperemia, corneal epithelium defect, Detachment of the retinal pigment epithelium, injection site pain, Foreign body sensation in eyes, Lacrimation increased, Vision blurred, Intraocular inflammation, Retinal pigment epithelium tear, injection site hemorrhage, Eyelid edema, corneal edema, hypersensitivity, retinal tear, Diabetic Macular Edema"
116,EYLEA,warnings and precautions,"Endophthalmitis, Retinal detachments, Increases in intraocular pressure, Arterial thromboembolic events (ATEs), Nonfatal stroke, Nonfatal myocardial infarction, Vascular death"
117,JEVTANA,adverse reactions,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Embryo-Fetal Toxicity, Neutropenia, Anemia, Leukopenia, Thrombocytopenia, Diarrhea, Fatigue, Nausea, Vomiting, Constipation, Asthenia, Abdominal Pain, Hematuria, Back Pain, Anorexia, Peripheral Neuropathy, Pyrexia, Dyspnea, Dysgeusia, Cough, Arthralgia, Alopecia, Infections, Febrile Neutropenia, Ventricular Fibrillation, Cerebral Hemorrhage, Arrhythmia, Peripheral Edema, Mucosal Inflammation, Pain, Urinary Tract Infection, Weight Decreased, Dehydration, Muscle Spasms, Dizziness, Headache, Dysuria, Hypotension, Sepsis, Septic Shock, Hepatic Laboratory Abnormalities, Gastritis, Intestinal Obstruction."
118,JEVTANA,boxed warnings,"neutropenia, neutropenic deaths, hypersensitivity, severe hypersensitivity reactions, generalized rash/erythema, hypotension, bronchospasm."
119,JEVTANA,warnings and precautions,"bone marrow suppression, neutropenia, febrile neutropenia, neutropenic infections, anemia, thrombocytopenia, pancytopenia, hypersensitivity reactions, gastrointestinal disorders, nausea, vomiting, diarrhea, gastrointestinal hemorrhage, gastrointestinal perforation, neutropenic enterocolitis, renal failure, hepatic impairment, fetal harm, embryotoxicity, fetotoxicity, abortifacient, hypersensitivity, sepsis, septic shock, electrolyte imbalance, ileus, enterocolitis, obstruction, obstructive uropathy, pelvic radiotherapy, adhesions, ulceration, GI bleeding"
120,YERVOY,adverse reactions,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, active autoimmune disease, systemic immunosuppression, unresectable melanoma, metastatic melanoma, hepatotoxicity, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), hypersensitivity, anaphylaxis"
121,YERVOY,boxed warnings,"immune-mediated adverse reactions, enterocolitis, hepatitis, dermatitis, toxic epidermal necrolysis, neuropathy, endocrinopathy"
122,YERVOY,warnings and precautions,"immune-mediated reactions, severe immune-mediated reactions, fatal immune-mediated reactions, immune-mediated hepatitis, immune-mediated endocrinopathies, immune-mediated Enterocolitis, intestinal perforation, severe enterocolitis, fatal (diarrhea of 7 or more stools above baseline, fever, ileus, peritoneal signs; Grade 3-5) enterocolitis, moderate enterocolitis, moderate immune-mediated adverse reactions, severe immune-mediated adverse reactions, hepatotoxicity, fatal hepatotoxicity, liver function test abnormalities, immune-mediated hepatitis, immune-mediated dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, rash complicated by full thickness dermal ulceration, necrotic, bullous, or hemorrhagic manifestations, severe dermatitis, moderate dermatitis, immune-mediated neuropathies, Guillain-Barre syndrome, peripheral motor neuropathy, myasthenia gravis, Guillain-Barre-like syndromes, motor or sensory neuropathy, immune-mediated endocrinopathies, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, hyperthyroidism, Cushing's syndrome, hypophysitis, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis"
123,FARXIGA,adverse reactions,"Hypotension, Renal Function Impairment, Hypoglycemia, Genital Mycotic Infections, Increase in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, Nasopharyngitis, Urinary Tract Infections, Back Pain, Increased Urination, Male Genital Mycotic Infections, Nausea, Influenza, Dyslipidemia, Constipation, Discomfort with Urination, Pain in Extremity, Volume Depletion, Dehydration, Hypovolemia, Orthostatic Hypotension, Renal Failure, Blood Creatinine Increase, Bone Fractures, Hypersensitivity Reactions, Angioedema, Urticaria, Hematocrit Increase, Hyperphosphatemia, Pollakiuria, Polyuria, Vulvovaginal Mycotic Infection, Vaginal Infection, Vulvovaginal Candidiasis, Vulvovaginitis, Genital Infection, Genital Candidiasis, Fungal Genital Infection, Vulvitis, Genitourinary Tract Infection, Vulval Abscess, Vaginitis Bacterial, Cystitis, Escherichia Urinary Tract Infection, Pyelonephritis, Trigonitis, Urethritis, Kidney Infection, Prostatitis, Balanitis, Balanitis Candida, Penile Infection, Balanoposthitis, Balanoposthitis Infective, Anaphylactic Reactions, Severe Cutaneous Adverse Reactions."
124,FARXIGA,warnings and precautions,"Hypotension, renal impairment, low systolic blood pressure, diuretics-induced hypovolemia, hypoglycemia, genital mycotic infections, increased LDL-C, bladder cancer, macrovascular risk."
125,PICATO,adverse reactions,"ophthalmic adverse reaction, hypersensitivity reactions, local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn"
126,PICATO,warnings and precautions,"eye disorders, severe eye pain, chemical conjunctivitis, corneal burn, eyelid edema, eyelid ptosis, periorbital edema, local skin reactions, vesiculation/pustulation, erosion/ulceration, hypersensitivity reactions, anaphylaxis, allergic contact dermatitis, erythema, crusting, swelling"
127,PRISTIQ,adverse reactions,"hypersensitivity, suicidal thoughts and behaviors, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, tachycardia, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, urinary retention, rash, alopecia, photosensitivity reaction, angioedema, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, lipid abnormalities, proteinuria, sustained hypertension, orthostatic hypotension, Stevens-Johnson syndrome"
128,PRISTIQ,boxed warnings,"suicidal thoughts and behaviors, depression (implied by the context of antidepressant use)"
129,PRISTIQ,warnings and precautions,"clinical worsening, suicide risk, Serotonin Syndrome, Elevated Blood Pressure, hypertension, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Bipolar Disorder, mania, hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, major depressive disorder (MDD), suicidal ideation, suicidality, suicidal thoughts and behaviors, obsessive compulsive disorder (OCD), anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, mania, psychiatric disorders, gastrointestinal bleeding, ecchymosis, hematoma, epistaxis, petechiae, hemorrhages, dysphoric mood, sensory disturbances, paresthesia, electric shock sensations, confusion, lethargy, emotional lability, hypomania, tinnitus, progressive dyspnea, cough, chest discomfort."
130,STRIBILD,adverse reactions,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Acute Exacerbations of Hepatitis B, Renal Impairment, Bone Effects, Immune Reconstitution Syndrome, Nausea, Diarrhea, Ocular Icterus, Flatulence, Fatigue, Jaundice, Somnolence, Headache, Dizziness, Insomnia, Abnormal Dreams, Rash, Suicidal Ideation, Suicide Attempt, Depression, Abdominal Pain, Dyspepsia, Vomiting, Fever, Pain, Nasopharyngitis, Pneumonia, Sinusitis, Upper Respiratory Tract Infection, Arthralgia, Back Pain, Myalgia, Paresthesia, Peripheral Neuropathy, Peripheral Neuritis, Anxiety, Cough, Rhinitis, Hyperpigmentation, Hematuria, Bone Mineral Density Decrease, Bone Fractures, Proteinuria, Serum Creatinine Increase, Creatinine Clearance Decrease, AST Elevation, ALT Elevation, Amylase Elevation, Creatine Kinase Elevation, Urine Red Blood Cells Elevation, Laboratory Abnormality, Alkaline Phosphatase Elevation, Bilirubin Elevation, Serum Glucose Abnormality, Glycosuria, Neutrophil Count Decrease, Fasting Cholesterol Elevation, Fasting Triglycerides Elevation, Total Cholesterol Elevation, HDL-cholesterol Elevation, LDL-cholesterol Elevation, Triglycerides Elevation, Allergic Reaction, Angioedema, Hypokalemia, Hypophosphatemia, Dyspnea, Pancreatitis, Increased Amylase, Hepatic Steatosis, Hepatitis, Increased Liver Enzymes, Gamma GT Elevation, Rhabdomyolysis, Osteomalacia, Muscular Weakness, Myopathy, Acute Renal Failure, Renal Failure, Acute Tubular Necrosis, Fanconi Syndrome, Proximal Renal Tubulopathy, Interstitial Nephritis, Nephrogenic Diabetes Insipidus, Renal Insufficiency, Increased Creatinine, Polyuria, Asthenia."
131,STRIBILD,boxed warnings,"Lactic acidosis, Severe hepatomegaly with steatosis, Fatal cases, Chronic hepatitis B virus (HBV) infection, Severe acute exacerbations of hepatitis B, HIV-1 coinfection"
132,STRIBILD,warnings and precautions,"renal impairment, acute renal failure, Fanconi syndrome, osteoporosis, bone loss, pathologic fracture, lactic acidosis, severe hepatomegaly with steatosis, hepatitis B, acute exacerbations of hepatitis B, liver decompensation, liver failure, proximal renal tubulopathy, bone pain, pain in extremities, fractures, muscular pain, muscle weakness, creatinine clearance reduction, chronic hepatitis B virus (HBV) infection, bone mineral density (BMD) decrease, bone turnover increase, osteomalacia, arthralgias, hypophosphatemia, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", immune reconstitution syndrome, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
133,NULOJIX,adverse reactions,"PTLD, CNS PTLD, malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, non-melanoma skin cancer, progressive multifocal leukoencephalopathy, bacterial infections, mycobacterial infections, viral infections, fungal infections, tuberculosis, herpes infections, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, infusion reactions, proteinuria, immunogenicity, anti-belatacept antibodies, new-onset diabetes after transplantation (NODAT), dyslipidemia, BK virus-associated nephropathy, renal impairment, renal artery stenosis, urinary incontinence, hydronephrosis, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, acute renal failure, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation, blood creatinine increased, arthralgia, back pain, dizziness, tremor, acne, insomnia, anxiety."
134,NULOJIX,boxed warnings,"post-transplant lymphoproliferative disorder (PTLD), central nervous system (CNS) involvement, malignancies, serious infections, Epstein-Barr virus (EBV) seronegative, Epstein-Barr virus (EBV) seropositive, infections, graft loss, death"
135,NULOJIX,warnings and precautions,"Post-Transplant Lymphoproliferative Disorder (PTLD), Central Nervous System (CNS) involvement, malignancies, skin cancer, Progressive Multifocal Leukoencephalopathy (PML), bacterial infections, viral infections, fungal infections, protozoal infections, opportunistic infections, tuberculosis, Polyoma virus-associated nephropathy (PVAN), kidney graft loss, liver transplant complications, acute rejection, Graft Loss, Corticosteroid Minimization, Epstein-Barr Virus (EBV) seronegative patients, Cytomegalovirus (CMV) infection, Cytomegalovirus disease, herpes, Pneumocystis jiroveci infection, BK virus infection, JC virus-associated PML, liver allograft involvement."
136,LUMIZYME,adverse reactions,"hypersensitivity reactions, anaphylaxis, rash, pyrexia, flushing, feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension, increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, angioedema, chest pain, angioedema, throat tightness, supraventricular tachycardia, Wolff-Parkinson-White syndrome, local swelling, diarrhea, pruritus, paresthesia, peripheral edema, rash papular, allergic reactions, flu-like illness, chills, arthralgia, pain, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, livedo reticularis, irritability, retching, increased lacrimation, cold sweat"
137,LUMIZYME,boxed warnings,"anaphylaxis, hypersensitivity reactions, immune-mediated reactions, cardiorespiratory failure, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, periorbital edema, face edema, urticaria, proteinuria, nephrotic syndrome, necrotizing skin lesions, compromised cardiac function, compromised respiratory function, serious acute exacerbation, Pompe disease, fluid overload."
138,LUMIZYME,warnings and precautions,"anaphylaxis, hypersensitivity reactions, immune-mediated reactions, acute cardiorespiratory failure, cardiac arrhythmia, sudden cardiac death, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, hypotension, angioedema, urticaria, convulsions, anaphylactic shock, cardiac arrest, respiratory arrest, throat tightness, wheezing, tachypnea, cyanosis, decreased oxygen saturation, pruritus, rash, hyperhidrosis, nausea, dizziness, hypertension, increased blood pressure, flushing, feeling hot, erythema, pyrexia, pallor, peripheral coldness, restlessness, nervousness, headache, back pain, paresthesia, necrotizing skin lesions, type III immune-mediated reactions, inflammatory arthropathy, pyrexia, elevated erythrocyte sedimentation rate, nephrotic syndrome, membranous glomerulonephritis, immune complex deposition, ventricular arrhythmias, antibody development, inhibitory antibody activity, IgE antibodies, IgG antibodies"
139,EOVIST,adverse reactions,"Nephrogenic systemic fibrosis (NSF), Hypersensitivity reactions, Nausea, Headache, Feeling hot, Dizziness, Back pain, Vomiting, Increased blood pressure, Injection site reactions, Dysgeusia, Paresthesia, Flushing, Parosmia, Pruritus, Rash, Respiratory disorders, Fatigue, Chest pain, Vertigo, Dry mouth, Chills, Feeling abnormal, Tremor, Akathisia, Bundle branch block, Palpitation, Oral discomfort, Salivary hypersecretion, Maculopapular rash, Hyperhidrosis, Discomfort, Malaise, Elevation of serum iron values, Elevated serum bilirubin, Anaphylactic shock, Hypotension, Pharyngolaryngeal edema, Urticaria, Face edema, Rhinitis, Conjunctivitis, Abdominal pain, Hypoesthesia, Sneezing, Cough, Pallor, Tachycardia, Restlessness."
140,EOVIST,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), chronic severe kidney disease, acute kidney injury, renal function reduction, hypertension, diabetes"
141,EOVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, impaired elimination of GBCAs, Hypersensitivity, anaphylactoid reactions, hypersensitivity reactions, shock, acute kidney injury, surgery, severe infection, injury, drug-induced kidney toxicity, chronic, severe kidney disease, chronic, moderate kidney disease, chronic, mild kidney disease, fatal fibrosis, debilitating fibrosis, acute kidney injury, chronically reduced renal function, diabetes mellitus, chronic hypertension, renal impairment, hemodialysis, hypersensitivity reactions, anaphylactic reactions, bronchial asthma, allergic disorders, Acute Kidney Injury, dialysis, Extravasation, Injection Site Reactions, myocyte necrosis, inflammation, Severe renal failure, hepatic failure, end-stage renal failure, elevated serum ferritin levels, abnormally high serum bilirubin."
142,BELEODAQ,adverse reactions,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, hepatic failure, ventricular fibrillation, febrile neutropenia"
143,BELEODAQ,warnings and precautions,"thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, infection, pneumonia, sepsis, hepatotoxicity, tumor lysis syndrome, embryo-fetal toxicity, gastrointestinal toxicity, nausea, vomiting, diarrhea, fetal harm, teratogenicity, embryo-fetal lethality"
144,VICTRELIS,adverse reactions,"anemia, neutropenia, pancytopenia, hypersensitivity, fatigue, nausea, headache, dysgeusia, chronic hepatitis C, decreased appetite, asthenia, arthralgia, dizziness, insomnia, irritability, chills, alopecia, dry skin, rash, dry mouth, diarrhea, vomiting, dyspnea exertional, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma, agranulocytosis"
145,VICTRELIS,warnings and precautions,"embryofetal toxicity, birth defects, fetal death, anemia, neutropenia, hypersensitivity reactions, urticaria, angioedema, pancytopenia, thromboembolic events, pulmonary embolism, acute myocardial infarction, cerebrovascular accident, deep vein thrombosis, infections."
146,VIMIZIM,adverse reactions,"anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, MPS IVA (Mucopolysaccharidosis type IVA), immunogenicity, anti-drug antibodies, neutralizing antibodies."
147,VIMIZIM,boxed warnings,"anaphylaxis, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, acute respiratory illness, hypersensitivity reactions"
148,VIMIZIM,warnings and precautions,"anaphylaxis, hypersensitivity reactions, acute respiratory complications, acute febrile illness, respiratory illness, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, peripheral edema, fever, sleep apnea, spinal or cervical cord compression (SCC), back pain, paralysis, urinary incontinence, fecal incontinence"
149,SIRTURO,adverse reactions,"increased mortality, QT Prolongation, hepatotoxicity, drug interactions, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, transaminases increased, rash, blood amylase increased, aminotransferase elevations, alanine aminotransferase increased, aspartate aminotransferase increased, tuberculosis-related death"
150,SIRTURO,boxed warnings,"increased mortality, death, QT prolongation, ventricular arrhythmia"
151,SIRTURO,warnings and precautions,"QT prolongation, significant ventricular arrhythmia, hepatotoxicity, increased mortality, Torsade de Pointes, congenital long QT syndrome, hypothyroidism, bradyarrhythmias, uncompensated heart failure, ventricular arrhythmias, myocardial infarction, syncope, liver injury, hepatitis, fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly, aminotransferase elevations, bilirubin elevation."
152,NEURACEQ,adverse reactions,"erythema, irritation, pain"
153,NEURACEQ,warnings and precautions,"image interpretation errors, false positives, long-term cumulative radiation exposure, radiation risk, cancer, severe brain atrophy, motion artifacts, brain neuritic beta-amyloid plaques."
154,COMETRIQ,adverse reactions,"Perforations, Fistula, Hemorrhage, Thromboembolic Events, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar erythrodysesthesia syndrome (PPES), Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, Diarrhea, Stomatitis, Decreased weight, Decreased appetite, Nausea, Fatigue, Oral pain, Hair color changes, Dysgeusia, Abdominal pain, Constipation, Increased AST (Aspartate aminotransferase), Increased ALT (Alanine aminotransferase), Lymphopenia, Increased ALP (Alkaline phosphatase), Hypocalcemia, Neutropenia, Thrombocytopenia, Hypophosphatemia, Hyperbilirubinemia, Pneumonia, Septicemia, Cardiac arrest, Respiratory failure, unspecified death, Hypocalcemia, Increased lipase, Pancreatitis, Tracheal fistula formation, Vomiting, Increased levels of thyroid stimulating hormone (TSH), Thyroidectomy, Thyroid hormone replacement, Dysphagia, Dyspepsia, Hemorrhoids, Asthenia, Dehydration, Arthralgia, Muscle spasms, Musculoskeletal chest pain, Headache, Dizziness, Paresthesia, Peripheral sensory neuropathy, Peripheral neuropathy, Anxiety, Dysphonia, Rash, Dry skin, Alopecia, Erythema, Hyperkeratosis, Hypotension, Hypomagnesemia, Hypokalemia, Hyponatremia."
155,COMETRIQ,boxed warnings,"gastrointestinal perforations, fistula formation, perforation, fistula, hemorrhage, severe hemorrhage, hemoptysis, gastrointestinal hemorrhage, fatal hemorrhage, bleeding, severe bleeding"
156,COMETRIQ,warnings and precautions,"myocardial infarction, cerebral infarction, arterial thromboembolic events, dehiscence, wound complications, hypertension, hypertensive crisis, osteonecrosis of the jaw, Palmar-plantar Erythrodysesthesia syndrome (PPES), proteinuria, nephrotic syndrome, Reversible posterior leukoencephalopathy syndrome (RPLS), Gastrointestinal (GI) perforation, fistulas, tracheal/esophageal fistulas, hemorrhage, hemoptysis, venous thromboembolism, arterial thromboembolism, severe hypertension, ONJ, jaw pain, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration, jaw or mouth slow healing after dental surgery, intolerable Grade 2 PPES, Grade 3-4 PPES, subcortical vasogenic edema, seizures, headache, visual disturbances, confusion, altered mental function, hepatic impairment, Embryo-fetal toxicity, embryolethal, skeletal variations, visceral variations, malformations. 

Please note that some terms are not direct synonyms but related conditions or specific manifestations of a condition (e.g., jaw pain, toothache) or are descriptive of the severity or related complications (e.g., severe hypertension). They are included as they provide additional context to medical conditions mentioned in the text."
157,AFINITOR,adverse reactions,"Non-infectious pneumonitis, Infections, Angioedema, Oral ulceration, Renal failure, Impaired wound healing, Hormone Receptor-Positive Breast Cancer, Metastatic breast cancer, HER2-negative breast cancer, Hyperglycemia, Dyspnea, Anemia, Leukopenia, Thrombocytopenia, Lymphopenia, Increased aspartate transaminase (AST), Increased alanine transaminase (ALT), Hypertriglyceridemia, Pancytopenia, Advanced Pancreatic Neuroendocrine Tumors (PNET), Advanced Renal Cell Carcinoma (RCC), Renal angiomyolipoma, Tuberous Sclerosis Complex, Subependymal giant cell astrocytoma (SEGA), Hypercholesterolemia, Elevated partial thromboplastin time, Neutropenia, Hypertriglyceridemia, Hypophosphatemia, Acute renal failure, Acute respiratory distress, Cardiac arrest, Death, Hepatic failure, Pneumonia, Sepsis, Pulmonary embolism, Hypoglycemia, Myocardial infarction, Congestive heart failure, Thrombosis, Pulmonary embolus, Hemorrhoids, Dysphagia, Impaired wound healing, Pleural effusion, Pharyngolaryngeal pain, Rhinorrhea, Hand-foot syndrome, Palmar-plantar erythrodysesthesia syndrome, Nail disorder, Erythema, Onychoclasis, Skin lesion, Acneiform dermatitis, Angioedema, Exacerbation of pre-existing diabetes mellitus, New onset of diabetes mellitus, Insomnia, Dizziness, Paresthesia, Conjunctivitis, Hypertension, Deep vein thrombosis, Renal and urinary disorders, Renal failure, Tachycardia, Congestive cardiac failure, Musculoskeletal and connective tissue disorders, Jaw pain, Hemorrhage, Amenorrhea, Menorrhagia, Menstrual irregularities, Vaginal hemorrhage, Lymphopenia, Cellulitis, Hyperglycemia, Elevated creatinine, Acute pancreatitis, Cholecystitis, Cholelithiasis, Arterial thrombotic events, Reflex sympathetic dystrophy"
158,AFINITOR,warnings and precautions,"non-infectious pneumonitis, infections, angioedema, oral ulceration, mouth ulcers, stomatitis, oral mucositis, renal failure, acute renal failure, impaired wound healing, wound-related complications, wound dehiscence, wound infection, incisional hernia, lymphocele, seroma, laboratory test alterations, hyperglycemia, hyperlipidemia, hypertriglyceridemia, anemia (decreases in hemoglobin), leukopenia (decreases in neutrophils), thrombocytopenia (decreases in platelets), embryo-fetal toxicity"
159,BREO,adverse reactions,"asthma-related death, asthma-related hospitalization, pneumonia in COPD, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, Candida albicans infection, back pain, pneumonia, bronchitis, sinusitis, cough, arthralgia, influenza, pharyngitis, pyrexia, viral respiratory tract infection, pharyngitis, pyrexia, arthralgia, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, rhinitis, arthralgia, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, pneumonia, asthma exacerbations, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness"
160,BREO,boxed warnings,"asthma, asthma-related death, asthma-related hospitalization"
161,BREO,warnings and precautions,"asthma-related death, asthma-related hospitalizations, COPD, acute asthma, acute symptoms, Candida albicans infection, mouth infection, pharynx infection, pneumonia, tuberculosis, fungal infection, bacterial infection, viral infection, parasitic infection, ocular herpes simplex, chickenpox, measles, adrenal insufficiency, hypercorticism, paradoxical bronchospasm, cardiovascular disorders, bone mineral density decrease, glaucoma, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, growth velocity reduction in children and adolescents, adrenal suppression, adrenal crisis, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, supraventricular tachycardia, extrasystoles, arrhythmias, electrocardiographic changes, systemic fungal infections, systemic bacterial infections, systemic viral infections, systemic parasitic infections, allergic conditions, respiratory tract infections, trauma, surgery, infection-related stress, gastroenteritis, severe electrolyte loss, COPD exacerbation, asthma attack, systemically active corticosteroid withdrawal, joint pain, muscular pain, lassitude, depression, rhinitis, conjunctivitis, eczema, arthritis, eosinophilic conditions, milk protein allergy."
162,FIRAZYR,adverse reactions,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache, hypersensitivity reactions, anaphylactic reactions, hereditary angioedema (HAE)"
163,FIRAZYR,warnings and precautions,"laryngeal attacks, acute laryngeal HAE attacks, airway obstruction"
164,INVOKANA,adverse reactions,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia, Genital Mycotic Infections, Urinary Tract Infections, Vulvovaginal Pruritus, Constipation, Nausea, Abdominal Pain, Volume Depletion-Related Adverse Reactions (e.g., postural dizziness, orthostatic hypotension, syncope, dehydration), Increased Urination, Male Genital Mycotic Infections (e.g., candidal balanitis, balanoposthitis), Thirst, Fatigue, Loss of Strength or Energy (i.e., asthenia), Pancreatitis, Hypersensitivity Reactions (including erythema, rash, pruritus, urticaria, angioedema), Photosensitivity-Related Adverse Reactions, Falls, Renal-Related Adverse Reactions (e.g., increased blood creatinine, renal impairment, acute renal failure), Vulvovaginal Mycotic Infection, Vulvovaginal Candidiasis, Vulvovaginitis, Phimosis, Bone Fractures, Increases in Serum Potassium, Increases in Serum Magnesium, Increases in Serum Phosphate, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Increases in non-High-Density Lipoprotein Cholesterol (non-HDL-C), Increases in Hemoglobin, Decreases in Bone Mineral Density."
165,INVOKANA,warnings and precautions,"hypotension, renal impairment, impaired renal function, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C, low systolic blood pressure, renal function abnormalities, moderate renal impairment, genital mycotic infections (e.g., generalized urticaria), macrovascular outcomes."
166,VORAXAZE,adverse reactions,"allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea, vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, osteosarcoma, sarcomas, leukemia, lymphoma, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor, immunogenicity"
167,VORAXAZE,warnings and precautions,"serious allergic reactions, anaphylactic reactions"
168,NESINA,adverse reactions,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis"
169,NESINA,warnings and precautions,"acute pancreatitis, hypersensitivity reactions, anaphylaxis, angioedema, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic failure, hypoglycemia, arthralgia, macrovascular risk reduction, liver test abnormalities, fatty liver disease, liver injury, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice, severe and disabling arthralgia."
170,GILENYA,adverse reactions,"bradyarrhythmia, atrioventricular blocks, infections, progressive multifocal leukoencephalopathy, macular edema, posterior reversible encephalopathy syndrome, respiratory effects, liver injury, headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, bronchitis, herpes zoster, tinea versicolor, bradycardia, migraine, nausea, asthenia, alopecia, actinic keratosis, blood triglycerides increased, dyspnea, vision blurred, hypertension, lymphopenia, leukopenia, skin papilloma, dizziness, pneumonia, eczema, pruritus, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, lymphoma"
171,GILENYA,warnings and precautions,"Bradycardia, atrioventricular conduction, infections, Progressive multifocal leukoencephalopathy (PML), Macular edema, Posterior reversible encephalopathy syndrome (PRES), decrease in pulmonary function tests, liver injury, Blood pressure (BP), Bradyarrhythmia, Atrioventricular Blocks, Herpes Viral Infections, Cryptococcal infections, Varicella Zoster Virus, Respiratory Effects, Fetal Risk, Immune System Effects, herpes zoster, influenza, sinusitis, pneumonia, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster infections, encephalitis, multiorgan failure, cryptococcal meningitis, heart rate decrease, symptomatic bradycardia, hypotension, dizziness, fatigue, palpitations, chest pain, first-degree AV block, second-degree AV block (Mobitz Types I [Wenckebach], 2:1 AV blocks), third-degree AV block, AV block with junctional escape, transient asystole, unexplained death, syncope, lymphocyte count reduction, acute infections, chronic infections, herpetic infections, serious infections, varicella zoster virus antibody-negative patients, blurred vision, decreased visual acuity, diabetes mellitus, uveitis, reduced forced expiratory volume over 1 second (FEV1), reduced diffusion lung capacity for carbon monoxide (DLCO), dyspnea, elevated liver enzymes, hepatic dysfunction, jaundice, dark urine, severe hepatic impairment, hypertension, lymphopenia."
172,HALAVEN,adverse reactions,"neutropenia, anemia, asthenia, fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia, myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, thrombocytopenia, peripheral motor neuropathy, liver function test abnormalities, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis, neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus."
173,HALAVEN,warnings and precautions,"neutropenia, peripheral neuropathy, embryo-fetal toxicity, QT prolongation, congenital long QT syndrome, congestive heart failure, bradyarrhythmias, alanine aminotransferase elevation, aspartate aminotransferase elevation, Grade 4 neutropenia, febrile neutropenia, cytopenias, motor neuropathy, sensory neuropathy, fetal harm, teratogenicity, hypokalemia, hypomagnesemia."
174,INTELENCE,adverse reactions,"severe skin reactions, hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, Stevens-Johnson syndrome, toxic epidermal necrolysis, rhabdomyolysis"
175,INTELENCE,warnings and precautions,"Severe skin reactions, Life-threatening skin reactions, Fatal skin reactions, Stevens-Johnson syndrome, Hypersensitivity reaction, Toxic epidermal necrolysis, Erythema multiforme, Severe hypersensitivity, Rash with systemic symptoms, Liver transaminase elevations, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), Hepatic failure, Grade 3 rashes, Grade 4 rashes, Fat Redistribution, Central obesity, Dorsocervical fat enlargement (buffalo hump), Peripheral wasting, Facial wasting, Breast enlargement, Cushingoid appearance, Immune Reconstitution Syndrome, Inflammatory response, Mycobacterium avium infection, Cytomegalovirus, Pneumocystis jiroveci pneumonia (PCP), Tuberculosis, Autoimmune disorders, Graves’ disease, Polymyositis, Guillain-Barre syndrome."
176,AMYVID,adverse reactions,"headache, musculoskeletal pain, increased blood pressure, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, chills, insomnia, neck pain, infusion site rash, dysgeusia, pruritus, urticaria, flushing, hypertension, injection site hemorrhage, injection site irritation, injection site pain"
177,AMYVID,warnings and precautions,"image interpretation errors, false negatives, radiation risk, cancer, brain neuritic plaque density misestimation, errors in image interpretation, brain atrophy, motion artifacts, brain neuritic amyloid plaque content, increased risk of cancer"
178,ULESFIA,adverse reactions,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, head lice infestation, skin irritation, scalp irritation, pain, pruritus, erythema, edema, pyoderma, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation"
179,ULESFIA,warnings and precautions,"neonatal toxicity, gasping syndrome, eye irritation, contact dermatitis, metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, allergic dermatitis, irritant dermatitis"
180,OTEZLA,adverse reactions,"Psoriatic Arthritis, Psoriasis, Diarrhea, Nausea, Headache, Tension Headache, Upper Respiratory Tract Infection, Vomiting, Nasopharyngitis, Abdominal Pain Upper, Hypersensitivity, Weight Decrease, Gastroesophageal Reflux Disease, Dyspepsia, Decreased Appetite, Migraine, Cough, Rash, Plaque Psoriasis, Tension Headache, Fatigue, Dyspepsia, Insomnia, Back Pain, Migraine, Frequent Bowel Movements, Depression, Bronchitis, Tooth Abscess, Folliculitis, Sinus Headache."
181,OTEZLA,warnings and precautions,"Depression, Suicidal thoughts, Suicidal behavior, Suicidal ideation, Weight Decrease, Weight loss, Psoriatic arthritis, Psoriasis."
182,ILARIS,adverse reactions,"CAPS, SJIA, upper respiratory tract infections, infections, mild to moderate, serious infections, opportunistic infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, intra-abdominal abscess, appendectomy, rhinitis, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, tonsillitis, urinary tract infection, viral infection, hypersensitivity, anaphylactic reactions, neutropenia (decreased white blood cells, neutrophils), thrombocytopenia (decreased platelets), transaminitis (elevated transaminases), bilirubin elevation"
183,ILARIS,warnings and precautions,"serious infections, recurring infections, infections, upper respiratory tract infections, aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster, tuberculosis (TB), new tuberculosis, reactivation of latent tuberculosis, opportunistic infections, latent tuberculosis infection, malignancies, hypersensitivity reactions, anaphylactic reactions, immunosuppression, macrophage activation syndrome (MAS), rheumatic conditions, systemic juvenile idiopathic arthritis (SJIA)"
184,NATAZIA,adverse reactions,"serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, migraines, menstrual disorders, vomiting, acne, mood changes, weight increase, metrorrhagia, menorrhagia, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding, depression, mood swings, altered mood, depressed mood, dysthymic disorder, crying, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolism, arterial thromboembolism, pulmonary embolism, cerebral thrombosis, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms, abdominal pain, vulvovaginal candidiasis."
185,NATAZIA,boxed warnings,"serious cardiovascular events, combination oral contraceptives use"
186,NATAZIA,warnings and precautions,"thrombotic event, thromboembolic disorders, vascular problems, venous thromboembolism (VTE), arterial thromboses, strokes, myocardial infarctions, cardiovascular disease, retinal vein thrombosis, liver disease, jaundice, hepatic adenomas, intra-abdominal hemorrhage, hepatocellular carcinoma, liver cancers, oral contraceptive-related cholestasis, pregnancy-related cholestasis, high blood pressure, hypertension, uncontrolled hypertension, gallbladder disease, carbohydrate metabolic effects, lipid metabolic effects, glucose tolerance, dyslipidemia, hypertriglyceridemia, pancreatitis, headache, migraine, cerebrovascular event, bleeding irregularities, breakthrough bleeding, spotting, amenorrhea, oligomenorrhea, birth defects, depression, hereditary angioedema, chloasma, chloasma gravidarum."
187,DIFICID,adverse reactions,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, hyperglycemia, metabolic acidosis, hypersensitivity reactions, dyspnea, angioedema, rash, pruritus"
188,DIFICID,warnings and precautions,"systemic infections, acute hypersensitivity reactions, angioedema, dyspnea, pruritus, rash, drug-resistant bacteria, C. difficile infection, allergy to other macrolides."
189,ONFI,adverse reactions,"somnolence, sedation, withdrawal symptoms, serious dermatological reactions, physical dependence, psychological dependence, suicidal behavior, suicidal ideation, constipation, pyrexia, lethargy, drooling, ataxia, aggression, fatigue, insomnia, gastrointestinal disorders, vomiting, dysphagia, general disorders, irritability, infections, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, metabolism and nutrition disorders, decreased appetite, increased appetite, nervous system disorders, somnolence, sedation, lethargy, drooling, ataxia, psychomotor hyperactivity, dysarthria, psychiatric disorders, aggression, insomnia, respiratory disorders, cough, blood disorders, anemia, eosinophilia, leukopenia, thrombocytopenia, eye disorders, diplopia, vision blurred, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, aspiration, respiratory depression, rash, urticaria, angioedema, facial edema, lip edema."
190,ONFI,warnings and precautions,"somnolence, sedation, central nervous system (CNS) depression, withdrawal, serious dermatological reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, physical and psychological dependence, substance abuse, habituation, suicidal behavior, suicidal ideation, depression, convulsions, psychosis, hallucinations, behavioral disorder, tremor, anxiety, dysphoria, insomnia, seizure exacerbation, status epilepticus"
191,TECFIDERA,adverse reactions,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy, lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus (itching), rash, albuminuria (albumin urine present), erythema, dyspepsia, aspartate aminotransferase increased, eosinophilia, hepatic transaminases elevation"
192,TECFIDERA,warnings and precautions,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy (PML), lymphopenia, multiple sclerosis (MS), infections, serious infections, flushing"
193,DYSPORT,adverse reactions,"distant spread of toxin effect, lack of interchangeability between botulinum toxin products, spread of effects from toxin, dysphagia, breathing difficulties, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, blurred vision, diplopia, reduced visual acuity, accommodation issues, cervical dystonia, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, upper limb spasticity, urinary tract infection, dizziness, fall, depression, disturbance in attention, eyelid disorder, feeling abnormal, muscle atrophy, dyspnea, diabetes, electrocardiographic changes, heart rate reduction, blood glucose increase, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site bruising, injection site reaction, eyelid ptosis, eyelid edema, constipation, diarrhea, injury, contusion, fall, injury, pain in extremity, hypertension, gait disturbance, hypertonia, sensation of heaviness, erythema, granulation tissue, facial paresis, hypoesthesia, amyotrophy, photophobia, influenza-like illness, burning sensation, vertigo."
194,DYSPORT,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, spasticity"
195,DYSPORT,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, neuromuscular disorder, Creutzfeldt-Jakob disease (CJD), asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, spasticity, cervical dystonia, respiratory failure, facial anatomical alterations, excessive muscle weakness, muscle atrophy, facial asymmetry, inflammation, eyelid ptosis, dermatochalasis, deep dermal scarring, thick sebaceous skin, peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, neuromuscular junction disorders, myasthenia gravis, Lambert-Eaton syndrome, hyperhidrosis"
196,ZYTIGA,adverse reactions,"hypertension, hypokalemia, fluid retention, mineralocorticoid excess, adrenocortical insufficiency, hepatotoxicity, fatigue, joint swelling, discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, metastatic castration-resistant prostate cancer, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain, cardiac failure, pyrexia, groin pain, constipation, insomnia, falls, nasopharyngitis, hematuria, rash, hypernatremia, cardiorespiratory arrest, myocardial ischemia, myocardial infarction, non-infectious pneumonitis, myopathy, rhabdomyolysis."
197,ZYTIGA,warnings and precautions,"cardiovascular disease, left ventricular ejection fraction (LVEF) < 50%, New York Heart Association (NYHA) Class III heart failure, NYHA Class IV heart failure, NYHA Class II heart failure, hypertension, hypokalemia, fluid retention, edema, heart failure, recent myocardial infarction, ventricular arrhythmia, adrenocortical insufficiency, liver enzymes increase, hepatotoxicity, ALT increase, AST increase, moderate hepatic impairment, liver function test abnormalities, bilirubin levels increase."
198,DUAVEE,adverse reactions,"Cardiovascular Disorders, Malignant Neoplasms, Gallbladder Disease, Hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, all-cause mortality, serious adverse reactions, hot flush, Venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis"
199,DUAVEE,boxed warnings,"endometrial cancer, cardiovascular disorders, probable dementia, endometrial hyperplasia, abnormal genital bleeding, stroke, deep vein thrombosis (DVT), osteoporosis, hot flushes, surgical menopause, breast cancer, cancer of the ovary, gallbladder problems, high blood pressure, increased fats in the blood, liver problems, thyroid problems, fluid retention, swelling of the mouth or tongue, asthma, diabetes, epilepsy, migraines, porphyria, lupus, bleeding disorder."
200,DUAVEE,warnings and precautions,"cardiovascular disorders, venous thromboembolism (VTE), pulmonary embolism, stroke, retinal vascular thrombosis, malignant neoplasms, endometrial cancer, breast cancer, ovarian cancer, gallbladder disease, loss of vision, severe hypertriglyceridemia, cholestatic jaundice, thyroid function, probable dementia, visual abnormalities, elevated blood pressure, hypertriglyceridemia, hepatic impairment, past history of cholestatic jaundice, hypothyroidism, fluid retention, cardiac dysfunction, renal impairment, hypocalcemia, hereditary angioedema, exacerbation of asthma, diabetes mellitus, epilepsy, migraine, systemic lupus erythematosus, hepatic hemangioma, premenopausal conditions, laboratory test abnormalities, impaired glucose tolerance."
201,SAPHRIS,adverse reactions,"Dementia-Related Psychosis, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, Hypersensitivity Reactions, Oral ulcers, Blisters, Peeling, Inflammation, Orthostatic Hypotension, Syncope, Hemodynamic Effects, Leukopenia, Neutropenia, Agranulocytosis, QT Interval Prolongation, Hyperprolactinemia, Seizures, Cognitive Impairment, Motor Impairment, Body Temperature Regulation, Suicide, Dysphagia, Schizophrenia, Akathisia, Oral hypoesthesia, Somnolence, Manic episodes, Bipolar I disorder, Increased weight, Dizziness, Extrapyramidal symptoms, Nausea, Increased appetite, Fatigue, Dysgeusia, Oral paresthesia, Application site reactions, Choking, Oropharyngeal muscular dysfunction."
202,SAPHRIS,boxed warnings,dementia-related psychosis
203,SAPHRIS,warnings and precautions,"cerebrovascular adverse events, stroke, transient ischemic attack, dementia-related psychoses, Neuroleptic Malignant Syndrome (NMS), Tardive Dyskinesia, metabolic changes, hyperglycemia, dyslipidemia, weight gain, cardiovascular/cerebrovascular risk, Hypersensitivity Reactions, anaphylaxis, angioedema, Orthostatic Hypotension, Syncope, Hemodynamic Effects, Leukopenia, Neutropenia, Agranulocytosis, QT Prolongation, Seizures, Cognitive Impairment, Motor Impairment, Suicide, Schizophrenia, Bipolar Disorder, Increased Mortality, Elderly Patients, infection, pneumonia, heart failure, sudden death, Increase in Weight, systemic infection, extrapyramidal signs and symptoms (EPS), central anticholinergic toxicity, heat stroke, drug fever, Diabetes Mellitus, Diabetes, D2receptors, prolactin levels, Hyperprolactinemia, galactorrhea, amenorrhea, gynecomastia, impotence, hypothalamic GnRH, pituitary gonadotropin secretion, reproductive function, hypogonadism, bone density, body temperature regulation, Body Temperature Increases, pyrexia, Dysphagia, Aspiration Pneumonia, myocardial infarction, unstable heart disease, rhabdomyolysis, acute renal failure, bradycardia, diaphoresis, cardiac dysrhythmia, respiratory depression, central nervous system depression, Ischemic heart disease, heart disease, cardiomyopathy, tachycardia, frozen shoulder, ketoacidosis, hyperosmolar coma, polydipsia, polyuria, polyphagia, weakness, obesity, family history of diabetes, fasting glucose testing, cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, prolactin-elevating compounds, Gynecomastia, gonadal steroidogenesis, female patients, male patients."
204,DUREZOL,adverse reactions,"elevated intraocular pressure, optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection, herpes simplex, perforation of the globe, thinning of the cornea, thinning of the sclera, corneal edema, ciliary hyperemia, conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort, application site irritation, corneal pigmentation, corneal striae, episcleritis, eye pruritus, eyelid irritation, eyelid crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal hyperemia, dry eye, iridocyclitis."
205,DUREZOL,warnings and precautions,"intraocular pressure (IOP) increase, glaucoma, optic nerve damage, defects in visual acuity, defects in fields of vision, cataracts, posterior subcapsular cataract formation, delayed healing, bleb formation, corneal thinning, scleral thinning, cornea or sclera perforations, bacterial infections, purulent conditions, viral infections, herpes simplex, fungal infections, corneal fungal infections, corneal ulceration"
206,ZYDELIG,adverse reactions,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, diarrhea, pyrexia (fever), fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, hypertriglyceridemia, hyperglycemia, ALT elevations (alanine transaminase elevations), AST elevations (aspartate transaminase elevations), febrile neutropenia, gastroesophageal reflux disease, stomatitis, headache, nasal congestion, sepsis, bronchitis, sinusitis, urinary tract infection, arthralgia, lymphocyte count decreased, lymphocyte count increased, GGT increased (gamma-glutamyl transferase increased), hypoglycemia, hyponatremia, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, ALT increased, AST increased, neutrophils decreased, hemoglobin decreased, platelets decreased"
207,ZYDELIG,boxed warnings,"hepatic toxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, hepatotoxicity, pulmonary symptoms, bilateral interstitial infiltrates"
208,ZYDELIG,warnings and precautions,"severe cutaneous reactions, anaphylaxis, neutropenia, embryo-fetal toxicity, hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, toxic epidermal necrolysis (TEN), dermatitis exfoliative, rash, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder."
209,KALBITOR,adverse reactions,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, upper respiratory tract infection, fatigue, vomiting, pruritus, upper abdominal pain, hypersensitivity reaction"
210,KALBITOR,boxed warnings,"anaphylaxis, hereditary angioedema, hypersensitivity reactions, clinical hypersensitivity"
211,KALBITOR,warnings and precautions,"Hypersensitivity Reactions, Anaphylaxis, Hereditary Angioedema (HAE), Chest Discomfort, Flushing, Pharyngeal Edema, Pruritus, Rhinorrhea, Sneezing, Nasal Congestion, Throat Irritation, Urticaria, Wheezing, Hypotension, Rash."
212,ADCETRIS,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, progressive multifocal leukoencephalopathy, pulmonary toxicity, serious dermatologic reactions, relapsed classical Hodgkin lymphoma, systemic anaplastic large cell lymphoma, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, herpes simplex virus infections, varicella-zoster virus infections, Pneumocystis jiroveci pneumonia, lymphadenopathy, headache, dizziness, chills, edema peripheral, abdominal pain, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, pneumonia, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, acute respiratory distress syndrome (ARDS), toxic epidermal necrolysis."
213,ADCETRIS,boxed warnings,"Progressive Multifocal Leukoencephalopathy (PML), JC virus infection, death"
214,ADCETRIS,warnings and precautions,"Peripheral neuropathy, Anaphylaxis, Infusion reactions, Hematologic toxicities, Neutropenia, Fever, Serious infections, Opportunistic infections, Tumor lysis syndrome, Hepatotoxicity, Pulmonary Toxicity, Serious dermatologic reactions, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Embryo-fetal toxicity, Prolonged severe neutropenia, Grade 3 neutropenia, Grade 4 neutropenia, Thrombocytopenia, Anemia, Febrile neutropenia, Pneumonia, Bacteremia, Sepsis, Septic shock, Increased toxicity in the presence of severe renal impairment, Increased toxicity in the presence of moderate or severe hepatic impairment, Progressive Multifocal Leukoencephalopathy (PML), Noninfectious pulmonary toxicity, Pneumonitis, Interstitial lung disease, Acute respiratory distress syndrome (ARDS)."
215,BESIVANCE,adverse reactions,"bacterial conjunctivitis, conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
216,BESIVANCE,warnings and precautions,"bacterial conjunctivitis, resistant organisms, super-infection, non-susceptible organisms, fungi"
217,CLEVIPREX,adverse reactions,"Hypotension, Reflex Tachycardia, headache, nausea, vomiting, perioperative hypertension, severe hypertension, essential hypertension, Acute renal failure, Atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation (possible pulmonary shunting)"
218,CLEVIPREX,warnings and precautions,"hypotension, reflex tachycardia, heart failure, rebound hypertension, disorders of lipid metabolism, pheochromocytoma"
219,XTANDI,adverse reactions,"Seizure, Asthenia/fatigue, Back pain, Decreased appetite, Constipation, Arthralgia, Diarrhea, Hot flush, Upper respiratory tract infection, Peripheral edema, Dyspnea, Musculoskeletal pain, Weight decreased, Headache, Hypertension, Dizziness/vertigo, Metastatic prostate cancer, Metastatic Castration-Resistant Prostate Cancer (CRPC), Spinal Cord Compression, Cauda Equina Syndrome, Paresthesia, Mental Impairment Disorders, Hypoesthesia, Lower Respiratory Tract And Lung Infection, Insomnia, Anxiety, Hematuria, Pollakiuria, Fall, Non-pathologic Fractures, Pruritus, Dry Skin, Epistaxis, Muscular Weakness, Musculoskeletal Stiffness, Dizziness, Cognitive disorder, Memory impairment, Amnesia, Disturbance in attention, Nasopharyngitis, Sinusitis, Rhinitis, Pharyngitis, Laryngitis, Pneumonia, Lower respiratory tract infection, Bronchitis, Lung infection, Dysgeusia, Restless Legs Syndrome, Gynecomastia, Neutropenia, Thrombocytopenia, Elevations in ALT, Elevations in bilirubin, Infections, Sepsis, Falls, Fall-related Injuries, Non-pathologic fracture, Joint injuries, Hematomas, Hypertensive crisis."
220,XTANDI,warnings and precautions,"seizure, cerebral vascular accident (CVA), brain injury with loss of consciousness, transient ischemic attack, brain metastases, brain arteriovenous malformation"
221,BOSULIF,adverse reactions,"gastrointestinal toxicity, myelosuppression, hepatic toxicity, fluid retention, renal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, hepatotoxicity, chronic myelogenous leukemia (CML), chronic phase CML (CP CML), accelerated phase CML (AP CML), blast phase CML (BP CML), neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, QT interval prolongation, cardiovascular disease, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, gastric hemorrhage, upper gastrointestinal hemorrhage, chest pain, chest discomfort, hepatotoxicity, toxic hepatitis, cytolytic hepatitis, abormal hepatic function, liver disorder, liver injury, drug hypersensitivity, pneumonia, bronchopneumonia, lobar pneumonia, primary atypical pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, acne, erythema multiforme, exfoliative rash, drug eruption."
222,BOSULIF,warnings and precautions,"Gastrointestinal Toxicity, Diarrhea, Nausea, Vomiting, Abdominal Pain, Myelosuppression, Thrombocytopenia, Anemia, Neutropenia, Hepatic Toxicity, Liver Injury, ALT Elevation, AST Elevation, Fluid Retention, Pericardial Effusion, Pleural Effusion, Pulmonary Edema, Peripheral Edema, Renal Toxicity, Decline in eGFR, Renal Dysfunction, Kidney Failure, Embryofetal Toxicity, Fetal Harm."
223,CARBAGLU,adverse reactions,"Infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash."
224,CARBAGLU,warnings and precautions,"Hyperammonemia, brain injury, brain damage, death, NAGS deficiency, metabolic disorders, acute symptomatic hyperammonemia."
225,SIMPONI,adverse reactions,"serious infections, malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis (TB), invasive fungal infections, liver enzyme elevations, autoimmune disorders, lupus-like syndrome, ANA-positive, anti-dsDNA antibodies, infusion reaction, immunogenicity, antibodies to golimumab, neutralizing antibodies, adverse drug reactions, infections and infestations, nasopharyngitis, pharyngitis, laryngitis, rhinitis, influenza, herpes, bacterial infections, vascular disorders, skin and subcutaneous disorders, general disorders and administration site conditions, pyrexia, blood and lymphatic disorders, leukopenia, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, investigations, Alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, nervous system disorders, dizziness, paresthesia, gastrointestinal disorders, constipation, Neoplasm Benign and Malignant, melanoma, immune system disorders, systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, respiratory, thoracic and mediastinal disorders, interstitial lung disease, skin and subcutaneous tissue disorders, skin exfoliation, bullous skin reactions"
226,SIMPONI,boxed warnings,"serious infections, tuberculosis (TB), bacterial sepsis, invasive fungal infections, histoplasmosis, opportunistic infections, malignancy, lymphoma, active tuberculosis, latent tuberculosis, disseminated disease, extrapulmonary disease, invasive fungal infections, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, Legionella infection, Listeria infection, chronic infection, recurrent infection"
227,SIMPONI,warnings and precautions,"serious infections, active infection, invasive fungal infections, systemic illness, hepatitis B reactivation, HBV carriers, malignancies, lymphoma, heart failure, demyelinating disease, hypersensitivity reactions, anaphylaxis, opportunistic infections, bacterial infections, mycobacterial infections, viral infections, parasitic infections, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, tuberculosis, chronic infection, recurrent infection, tuberculosis exposure, endemic tuberculosis, endemic mycoses, predisposition to infection, reactivation of tuberculosis, new tuberculosis infections, latent tuberculosis, hepatitis B virus (HBV) reactivation, chronic hepatitis B, melanoma, non-melanoma skin cancer (NMSC), lymphomas, Hodgkin's lymphoma, non-Hodgkin's lymphoma, acute leukemia, chronic leukemia, hepatosplenic T-cell lymphoma (HSTCL), Merkel cell carcinoma, worsening congestive heart failure (CHF), new onset CHF, multiple sclerosis (MS), optic neuritis, peripheral demyelinating disorders, Guillain-Barre syndrome, central nervous system (CNS) demyelinating disorders, peripheral demyelinating polyneuropathy, pancytopenia, leukopenia, neutropenia, aplastic anemia, thrombocytopenia, cytopenias, serious systemic hypersensitivity reactions, anaphylactic reactions."
228,BENLYSTA,adverse reactions,"Mortality, Serious Infections, Malignancy, Hypersensitivity Reactions, Anaphylaxis, Infusion Reactions, Depression, Nausea, Diarrhea, Pyrexia, Nasopharyngitis, Bronchitis, Insomnia, Pain in extremity, Migraine, Pharyngitis, Cystitis, Leukopenia, Gastroenteritis viral, Lupus nephritis, Fatal anaphylaxis"
229,BENLYSTA,warnings and precautions,"mortality, serious infections, chronic infections, progressive multifocal leukoencephalopathy (PML), hypersensitivity reactions, anaphylaxis, depression, suicidality, immunization (context: live vaccines), malignancy, infusion reactions, bradycardia, myalgia, headache, rash, urticaria, hypotension, psychiatric events, insomnia, anxiety, other serious psychiatric disorders, cardiovascular disease, upper respiratory tract infection, urinary tract infection, nasopharyngitis, sinusitis, bronchitis, influenza, pneumonia, cellulitis, JC virus-associated PML, neurological deficits, non-melanoma skin cancers"
230,TOVIAZ,adverse reactions,"dry mouth, constipation, angina, chest pain, gastroenteritis, QT prolongation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, diverticulitis, irritable bowel syndrome, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus"
231,TOVIAZ,warnings and precautions,"Angioedema, bladder outlet obstruction, urinary retention, severe constipation, narrow-angle glaucoma, somnolence, central nervous system effects, hepatic impairment, renal impairment, myasthenia gravis."
232,ENTEREG,adverse reactions,dyspepsia
233,ENTEREG,boxed warnings,myocardial infarction
234,ENTEREG,warnings and precautions,"myocardial infarctions, chronic non-cancer pain, abdominal pain, nausea, vomiting, diarrhea, severe hepatic impairment, end-stage renal disease, complete gastrointestinal obstruction, bowel obstruction, pancreatic anastomosis, gastric anastomosis"
235,VIZAMYL,adverse reactions,"flushing, headache, increased blood pressure, nausea, dizziness, hypersensitivity reaction, dyspnea, chest pressure"
236,VIZAMYL,warnings and precautions,"hypersensitivity reactions, flushing, dyspnea, radiation risk, cancer, image interpretation errors, false positives, brain neuritic plaque density, extensive brain atrophy, motion artifacts."
237,AMPYRA,adverse reactions,"seizures, anaphylaxis, urinary tract infections, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, confusional state"
238,AMPYRA,warnings and precautions,"seizures, anaphylaxis, renal impairment, allergic reactions, urinary tract infections (UTIs)"
